Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E20.85 EPS (ttm)7.41 Insider Own0.10% Shs Outstand760.32M Perf Week-2.23%
Market Cap117.47B Forward P/E14.64 EPS next Y10.56 Insider Trans-9.99% Shs Float759.13M Perf Month-2.27%
Income5.71B PEG1.87 EPS next Q2.41 Inst Own82.40% Short Float1.27% Perf Quarter-0.01%
Sales20.58B P/S5.71 EPS this Y0.90% Inst Trans0.04% Short Ratio3.04 Perf Half Y-2.38%
Book/sh34.83 P/B4.44 EPS next Y10.23% ROA8.20% Target Price179.47 Perf Year28.15%
Cash/sh35.67 P/C4.33 EPS next 5Y11.17% ROE22.40% 52W Range112.79 - 172.75 Perf YTD-2.01%
Dividend3.16 P/FCF20.24 EPS past 5Y8.20% ROI10.20% 52W High-10.56% Beta0.54
Dividend %2.05% Quick Ratio5.10 Sales past 5Y6.50% Gross Margin80.70% 52W Low36.98% ATR3.08
Employees17900 Current Ratio5.50 Sales Q/Q11.30% Oper. Margin37.00% RSI (14)44.45 Volatility2.41% 1.96%
OptionableYes Debt/Eq1.14 EPS Q/Q50.70% Profit Margin27.70% Rel Volume0.87 Prev Close153.26
ShortableYes LT Debt/Eq1.13 EarningsJul 28 AMC Payout34.90% Avg Volume3.18M Price154.50
Recom2.40 SMA20-1.62% SMA50-2.89% SMA200-0.85% Volume2,769,842 Change0.81%
May-28-15Reiterated Deutsche Bank Buy $200 → $192
Apr-22-15Reiterated UBS Buy $175 → $185
Apr-22-15Reiterated RBC Capital Mkts Outperform $178 → $185
Oct-29-14Reiterated Argus Buy $140 → $185
Oct-28-14Reiterated RBC Capital Mkts Outperform $150 → $165
Sep-08-14Reiterated RBC Capital Mkts Outperform $138 → $150
Aug-04-14Reiterated Argus Buy $135 → $140
Jul-30-14Reiterated RBC Capital Mkts Outperform $125 → $138
Jul-18-14Reiterated Deutsche Bank Buy $144 → $149
Apr-23-14Reiterated Oppenheimer Perform $121 → $122
Mar-21-14Reiterated Barclays Equal Weight $115 → $130
Jan-31-14Reiterated Argus Buy $130 → $135
Nov-20-13Reiterated Deutsche Bank Buy $138 → $142
Aug-29-13Reiterated UBS Buy $121 → $124
Aug-27-13Reiterated Barclays Overweight $105 → $115
Jul-31-13Reiterated Oppenheimer Perform $100 → $109
Apr-24-13Reiterated Deutsche Bank Buy $108 → $115
Apr-15-13Reiterated Barclays Equal Weight $90 → $105
Apr-08-13Reiterated RBC Capital Mkts Outperform $95 → $105
Jan-25-13Upgrade Argus Hold → Buy $96
Jul-06-15 09:50AM  Healthcare Stocks Likely to Outperform despite Rate Hike
07:59AM  2 Dividend Stocks to Buy in a Market Crash at Motley Fool
Jun-30-15 02:43PM  Why is Celgene So Darn Expensive? at Barrons.com
01:18PM  Citigroup Still Says Sell AbbVie at Barrons.com
10:43AM  Is Celgene's Juno Deal a Boon or a Boondoggle? at Barrons.com
Jun-29-15 02:44PM  Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent
Jun-27-15 06:02PM  Biotech Short-Sellers Prefer Amgen To Gilead Sciences
Jun-25-15 12:44PM  Five Best Stocks to Buy According To Quant Billionaires at Insider Monkey
09:30AM  The Zacks Analyst Blog Highlights: BioMarin, Vical, Epizyme, Amgen and Medicines Co - Press Releases
Jun-24-15 08:44AM  Biotech Stock Roundup: BioMarin Jumps on Dwarfism Data, Vical Plunges on Vaccine Data - Analyst Blog
07:51AM  Inside Kite Pharma's 100% run
Jun-23-15 09:54PM  Amgen Dazzles With a Duo of Fresh Data at Investopedia
Jun-22-15 11:30AM  Amgen Presents Interim Data on Migraine Drug AMG 334 - Analyst Blog
01:03AM  Celimmune to Present Experimental Anti-IL-15 Antibody AMG 714 at 16th International Coeliac Disease Symposium PR Newswire
Jun-19-15 07:42PM  Better Dividend Stock: Amgen or Gilead Sciences? at Investopedia
04:05PM  Amgen Cancer Drug Vectibix Hits Phase III Primary Endpoint - Analyst Blog
04:00PM  Amgen Presents Open-Label Extension Data From Ongoing Phase 2 Study Of AMG 334 In The Prevention Of Episodic Migraine PR Newswire
03:44PM  Biotech bargain bin
01:41PM  Biotechs about to break out: Pro
12:48PM  Healthcare heats up in the summer
07:50AM  Early movers: HSY, RHT, SWHC, STT, CAG & more at CNBC
Jun-18-15 11:02PM  How Much Should Cancer Drugs Cost? at The Wall Street Journal
05:59PM  Amgen's cancer drug meets main goal in late-stage study
05:40PM  Biotech's big boost
04:26PM  Amgen cancer drug meets testing goal at MarketWatch
04:01PM  Results From Phase 3 Trial Show Vectibix® (Panitumumab) Improves Overall Survival In Chemorefractory Wild-Type KRAS Metastatic Colorectal Cancer Versus Best Supportive Care PR Newswire
02:54PM  Biotech ETF Hits Record: How Much Higher Can It Go? at Barrons.com
12:27PM  Teva Migraine Drug Succeeds In Midstage Trial at Investor's Business Daily
Jun-17-15 12:10PM  Frozen forehead meets double chin at Financial Times
Jun-16-15 12:39PM  We've Only Seen This Contrarian Buy Signal One Other Time Since 2009 at Forbes
Jun-15-15 02:13PM  Biotech's Rally Has Long-Term Legs, Asserts S&P Capital IQ Director at TheStreet
08:05AM  Hot Atara snags licensing deal with leading cancer center at bizjournals.com
Jun-14-15 05:12PM  Open Monoclonal Technology Announces OmniAb Alliance With Amgen Business Wire
Jun-12-15 08:00PM  IBD Market Wrap - 06/12/15
10:10AM  Stock Market News for June 12, 2015 - Market News
09:00AM  Steven Nissen, Conflicts Of Interest, And The New Cholesterol Drugs at Forbes
03:05AM  Edited Transcript of AMGN presentation 11-Jun-15 3:40pm GMT
Jun-11-15 04:30PM  Merck (MRK) Presents Multiple Biosimilar and Diabetes Data - Analyst Blog
03:42PM  Why Is Amgen Rising And Regeneron Falling? at Barrons.com
01:41PM  Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks
12:26PM  4 Stocks, 4 trades: BOX, FDX & more
08:59AM  Krispy Kreme pops; Lululemon founder sells stake; Nike inks NBA deal
08:10AM  Retail sales rebound; Nike's big NBA score; LA minimum wage hike
08:02AM  New Migraine Drugs Could Ease Investors' Headaches at Investor's Business Daily
01:11AM  FDA Panel Backs Amgens Cholesterol-Lowering Drug at The Wall Street Journal
Jun-10-15 09:32PM  This Trial Could Be Worth Billions to Amgen at Investopedia
08:10PM  Is This Johnson & Johnson's Next Blockbuster? at Investopedia
07:16PM  FDA Panel Recommends Amgen's Cholesterol-Lowering Drug at The Wall Street Journal
06:10PM  FDA panel backs Amgen cholesterol drug for some patients
05:52PM  After-hours buzz: Box, Krispy Kreme, Nike & more at CNBC
05:35PM  Amgen Cholesterol Drug Repatha Wins FDA Panel Vote at Investor's Business Daily
05:27PM  FDA panel backs Amgen cholesterol drug for some patients at Los Angeles Times
04:37PM  FDA panel backs Amgen's cholesterol drug for high-risk patients Reuters
04:01PM  Amgen Cholesterol Drug Wins Panels Backing for Some Patients at Bloomberg
03:44PM  UPDATE 3-FDA panel backs Sanofi/Regeneron cholesterol drug with limits Reuters
03:26PM  Live Blog: FDA Panel For Amgen's Cholesterol Drug Repatha at Forbes
12:49PM  Why a FDA nod isn't enough for Regeneron shares at CNBC
10:52AM  FDA Panel Clears Product Path For Sanofi, Regeneron Pharmaceuticals
10:24AM  Biotech Stock Roundup: FDA Panel Recommends Regeneron's Praluent, SAGE Gains on Data - Analyst Blog
10:06AM  How to Trade the Stocks of Four Giants in the Health Care Industry at TheStreet
09:10AM  Netflix hits fresh 52-week high; Apple Music probe; HCC surges on merger
08:15AM  Wall Street's funk; Target's dividend slip up; Apple's antitrust problem
08:00AM  Amgen To Discuss Details Of Repatha (Evolocumab) Biologics License Application For The Treatment Of High Cholesterol PR Newswire
07:21AM  Two drugs target 'bad' cholesterol: CEO
Jun-09-15 06:09PM  Regeneron/Sanofi Cholesterol Drug Wins FDA Panel Vote at Investor's Business Daily
06:09PM  Regeneron Cholesterol Fighter Gets FDA Panel's Backing, 13-3
05:25PM  Cholesterol drug wars
05:00PM  Amgen's Repatha Briefing Document Gives Mixed Review - Analyst Blog
01:01PM  Battling 'bad' cholesterol
08:30AM  FDA weighs target population for Amgen cholesterol drug
08:00AM  Two Big Biotech ETFs
06:31AM  FDA targets 'bad' cholesterol drug
Jun-08-15 09:59PM  This Key Amgen Drug Is Setting a Precedent at Investopedia
04:49PM  FDA weighs best patient group for Amgen cholesterol drug at Los Angeles Times
04:00PM  Amgen To Present At The Goldman Sachs Global Healthcare Conference PR Newswire
10:28AM  FDA weighs best patient group for Amgen cholesterol drug
10:07AM  Amgen's Repatha effective; question is for which patients--FDA Reuters
09:11AM  Amgen Cholesterol Drug Faces Question From FDA Staff on Benefit at Bloomberg
12:08AM  FDA Queues Up Review of Anti-Cholesterol Drugs at The Wall Street Journal
Jun-07-15 09:40AM  New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels at 24/7 Wall St.
Jun-06-15 08:02AM  Are 4 Top-Rated IBD 50 Drug Stocks On Your Radar? at Investor's Business Daily
05:33AM  FDA Reviews Anti-Cholesterol Drugs at The Wall Street Journal
Jun-05-15 05:16PM  FDA weighs approval of first-in-class cholesterol drug
04:54PM  Regeneron/Sanofi Cholesterol Drug Under FDA Scrutiny at Investor's Business Daily
10:44AM  The Fight Against Cholesterol Heats Up; FDA Panel Considers Drugs from Regeneron, Amgen Next Week at Barrons.com
09:36AM  FDA Staff Says Sanofi Drug Cuts Cholesterol, Questions Benefit at Bloomberg
08:00AM  Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease PR Newswire
Jun-04-15 05:25PM  Fighting 'bad' cholesterol
11:59AM  Amgen Subpoenas a Journalist as it Fights a Shareholder Lawsuit at The Wall Street Journal
11:49AM  Cramer -- Why Intel's Deal for Altera Was Needed; Costco Is a Buy at TheStreet
Jun-03-15 04:41PM  Novartis tries to get U.S. ban lifted on sale of Neupogen copycat Reuters
12:43PM  Amgen, Novartis Battle in Court on Copycat Version of Neupogen at Bloomberg
11:34AM  Biotech Stock Roundup: ImmunoGen Soars on ASCO Data, Amgen Collaborates with Roche - Analyst Blog
09:59AM  Amgen: The Quiet Winner at Barrons.com
Jun-02-15 04:42PM  Roche Collaborates with Amgen for Immuno-Oncology - Analyst Blog
04:00PM  [video]Why Health Care Stocks Will Continue to Lead Market Higher at TheStreet
10:30AM  Merck's Keytruda under Priority Review for Lung Cancer - Analyst Blog
01:00AM  Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab PR Newswire
Jun-01-15 03:29PM  AstraZeneca Nearing Decision on Suicide-Linked Drug, CEO Says at Bloomberg
12:39PM  ImmunoGen, Bristol make strides in cancer battle at MarketWatch
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine. The company's principal products include Neulasta, a pegylated protein to decrease the incidence of infection associated with chemotherapy-induced febrile neutropenia in cancer patients; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for reducing the incidence of infection as manifested by febrile neutropenia for patients with non-myeloid malignancies; and Enbrel to treat rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis in adult patients. Its principal products also comprise EPOGEN for the treatment of dialysis; Aranesp for treating anemia; XGEVA for the prevention of skeletal-related events; Prolia to treat postmenopausal women with osteoporosis; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in chronic kidney disease patients on dialysis. The company's other marketed products include Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; Vectibix, a human monoclonal antibody; and BLINCYTO for the treatment of patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It also develops various products that are in various clinical trials. The company serves pharmaceutical wholesale distributors; and healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. It has collaborative agreements with AstraZeneca Plc; Takeda Pharmaceutical Company Limited; UCB; and Bayer HealthCare Pharmaceuticals Inc. The company was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patton Cynthia MSVP & CCOJun 02Sale157.064,530711,48216,571Jun 03 07:16 PM
Balachandran MadhavanEVP, OperationsMay 07Option Exercise55.7221,7501,211,94855,144May 11 04:56 PM
Balachandran MadhavanEVP, OperationsMay 07Sale157.8721,7503,433,69533,394May 11 04:56 PM
Tross Stuart ASVP, Human ResourcesApr 23Sale169.313,012509,96421,923Apr 24 04:53 PM
Harper Sean EEVP, Research & DevelopmentApr 22Sale171.5828,0004,804,24047,920Apr 23 05:04 PM
Tross Stuart ASVP, Human ResourcesMar 03Sale157.744,415696,42720,237Mar 04 08:25 PM
BALTIMORE DAVIDDirectorMar 02Sale158.763,647579,01131,159Mar 03 08:55 PM
BALTIMORE DAVIDDirectorFeb 19Option Exercise42.135,000210,65036,159Feb 23 04:13 PM
Bradway Robert AChairman, CEO and PresidentFeb 11Option Exercise42.1384,0003,538,920258,641Feb 12 09:09 PM
Bradway Robert AChairman, CEO and PresidentFeb 11Sale152.6922,0003,359,116218,102Feb 12 09:09 PM
COFFMAN VANCE DDirectorFeb 06Option Exercise42.135,000210,65038,460Feb 06 06:23 PM
HERRINGER FRANK CDirectorFeb 05Option Exercise42.135,000210,65025,449Feb 05 08:11 PM
HERRINGER FRANK CDirectorFeb 05Buy152.293,000456,8702,000Feb 05 08:11 PM
de Carbonnel FrancoisDirectorDec 03Sale168.013,000504,04119,159Dec 03 05:00 PM
COFFMAN VANCE DDirectorSep 05Option Exercise56.7920,0001,135,80041,623Sep 09 06:54 PM
Harper Sean EEVP, Research & DevelopmentAug 05Sale127.2914,0001,782,12659,503Aug 07 04:22 PM
UNP Union Pacific Corporation daily Stock Chart
UNP [NYSE]
Union Pacific Corporation
IndexS&P 500 P/E16.40 EPS (ttm)5.87 Insider Own0.20% Shs Outstand878.78M Perf Week-0.55%
Market Cap84.57B Forward P/E14.13 EPS next Y6.81 Insider Trans-1.17% Shs Float877.42M Perf Month-5.41%
Income5.24B PEG1.22 EPS next Q1.41 Inst Own81.00% Short Float0.87% Perf Quarter-9.05%
Sales23.96B P/S3.53 EPS this Y22.10% Inst Trans0.01% Short Ratio1.34 Perf Half Y-18.06%
Book/sh23.95 P/B4.02 EPS next Y14.30% ROA10.00% Target Price118.00 Perf Year-2.90%
Cash/sh1.81 P/C53.29 EPS next 5Y13.49% ROE24.60% 52W Range94.84 - 123.30 Perf YTD-18.41%
Dividend2.20 P/FCF90.26 EPS past 5Y25.20% ROI17.10% 52W High-21.95% Beta1.01
Dividend %2.29% Quick Ratio1.10 Sales past 5Y11.10% Gross Margin75.90% 52W Low1.48% ATR1.47
Employees48830 Current Ratio1.30 Sales Q/Q-0.40% Oper. Margin37.00% RSI (14)32.38 Volatility1.31% 1.43%
OptionableYes Debt/Eq0.58 EPS Q/Q9.20% Profit Margin21.90% Rel Volume0.85 Prev Close96.66
ShortableYes LT Debt/Eq0.56 EarningsJul 23 BMO Payout33.30% Avg Volume5.68M Price96.24
Recom1.90 SMA20-3.17% SMA50-5.99% SMA200-13.17% Volume4,839,977 Change-0.43%
Jul-06-15Upgrade Cowen Market Perform → Outperform $117 → $111
Jun-08-15Reiterated Barclays Overweight $126 → $121
May-15-15Upgrade TD Securities Hold → Buy $125 → $120
Apr-10-15Upgrade Stifel Hold → Buy $120
Apr-06-15Reiterated UBS Buy $135 → $128
Jan-23-15Upgrade BB&T Capital Mkts Hold → Buy
Jan-23-15Reiterated UBS Buy $128 → $135
Jan-23-15Reiterated FBR Capital Outperform $130 → $140
Jan-23-15Reiterated Argus Buy $130 → $136
Jan-22-15Reiterated Cowen Outperform $122 → $138
Dec-12-14Reiterated Argus Buy $104 → $130
Dec-08-14Reiterated Argus Buy $104 → $130
Oct-24-14Reiterated RBC Capital Mkts Outperform $132 → $135
Oct-24-14Reiterated FBR Capital Outperform $120 → $130
Oct-14-14Initiated UBS Buy $123
Jun-30-14Reiterated Barclays Overweight $115 → $105
Jun-24-14Reiterated FBR Capital Mkt Perform $110 → $120
Jun-10-14Upgrade RBC Capital Mkts Sector Perform → Outperform $97 → $115
May-13-14Reiterated Argus Buy $193 → $208
Apr-17-14Reiterated Cowen Outperform $196 → $197
Jul-06-15 04:58PM  Cowen & Company Ups Union Pacific To Outperform
08:30AM  3 Defensive Stocks Offering Safety, Yield In A Turbulent Market
08:01AM  Analysts' Actions -- Aetna, GoPro, Union Pacific and More
05:55AM  Union Pacific upgraded by Cowen
Jul-01-15 07:01PM  Union Pacific imposing hefty surcharge on older crude railcars Reuters
12:51PM  Hedge Funds Hate These 5 Stocks -- but Should You? at TheStreet
09:54AM  10 Worst Industrial Stocks in the S&P 500 at TheStreet
Jun-30-15 03:37PM  2nd half of the year: Rail stocks
10:48AM  Jim Cramer 'Be Very Careful' Buying 'Terrible' Railroad Stocks at TheStreet
09:24AM  Cramer's Mad Dash: Rails challenged
Jun-29-15 09:50PM  Time for Dividend Investors to Buy Union Pacific? at Investopedia
10:00AM  Is Union Pacific Corporation Looking At A Possible Rebound This Year?
Jun-28-15 12:05AM  Coal Shipments Rise after Falling for 2 Straight Weeks
Jun-26-15 07:00PM  Cramer: Be very careful with these stocks!
03:08PM  Union Pacific Remains BMO's Top Pick, Here's Why
Jun-25-15 09:00AM  Union Pacific Corporation Invites You to Join Its Second Quarter 2015 Earnings Release Broadcast PR Newswire
08:42AM  Rough ride for railroad stocks
Jun-24-15 10:55PM  Can Key Support Cluster Get Railroad Stocks Back On Track?
06:00PM  Cramer: Just when we thought we had real leaders ...
03:38PM  Railroads some of biggest losers
09:27AM  Bank Of America: Demand Soft For Big Rail Carriers
Jun-22-15 11:40AM  Union Pacific, Smart & Final, Party City Are Buys Right Now at TheStreet
06:00AM  Three Stocks to Buy Now: Union Pacific, Smart & Final, Party City at TheStreet
Jun-19-15 11:02AM  UNION PACIFIC CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jun-18-15 02:30PM  Dump Union Pacific Corporation (UNP) Now: Here's Why - Analyst Blog
02:18PM  Union Pacific Launches Social Media-Based High School Senior Photo Safety Campaign PR Newswire
Jun-17-15 07:00AM  Railroads' Competitive Advantages Are Solid, but Challenges Lie Ahead at Morningstar
Jun-15-15 06:00PM  Cramer: Twitter, get it together -- or fail
Jun-11-15 06:00PM  Cramer: Free-fall in transports over
Jun-10-15 08:33AM  Buffett indicator, second highest in 50-years, as Berkshire breaks support
Jun-08-15 03:09PM  Closing Bell Exchange: Transportation sector hit hard
Jun-05-15 11:58PM  3 Reasons Union Pacific Stock May Fall at Investopedia
Jun-04-15 02:42PM  A slump in transportation stocks may no longer signal danger
Jun-03-15 02:52PM  CSX Sees U.S. Coal Volumes Down At Least 5% at Investor's Business Daily
01:32PM  Hedge Funds Hate These 5 Stocks -- but Should You? at TheStreet
Jun-02-15 09:01AM  Cramer: Buy autos-here's why
May-31-15 11:55AM  Union Pacific chief threatens action on oil train brake rules at Financial Times
May-29-15 05:16PM  Union Pacific Publishes Sustainability and Citizenship Report, Featuring Redesigned Online Version with Enhanced Visuals PR Newswire
02:31PM  One Reason Union Pacific (UNP) Stock Is Going Down at TheStreet
May-28-15 06:13PM  Union Pacific furloughs about 900 workers as shipments slow
12:52PM  Cars Will Drive Themselves Before Freight Trains Do
09:29AM  Investments for All Seasons
06:00AM  Jim Cramer's Top Takeaways: Hormel, Union Pacific, Integrated Device Technology at TheStreet
May-27-15 08:13PM  Jim Cramer's 'Mad Money' Recap: 'Hit and Run' Investors Are the Worst at TheStreet
07:08PM  Cramer Remix: Hey Fed-I've got something to say at CNBC
06:58PM  If you have to own a rail, Cramer picks UNP
06:45PM  Cramer: Transports screech as Union Pacific blazes at CNBC
06:25PM  Cramer takes a look at the housing landscape
06:15PM  Hormel CEO: Excited to enter natural & organic category
06:03PM  Union Pacific Plans to Invest $72 Million in its Louisiana Rail Infrastructure PR Newswire
06:00PM  Cramer: The reversal of the reversal
02:45PM  Union Pacific Moves to Offset Lower Cargo Volumes at The Wall Street Journal
01:34PM  Amtrak Crash Quells Railroads' Effort to Reduce Crews on Trains
01:30PM  Stocks rebound; Pros pick stocks
11:54AM  Transportation Stocks Flash Troublesome Signal at Forbes
May-25-15 09:37AM  5 Most Popular Transportation Stocks Among Hedge Funds ~ Delta Air Lines Inc. (DAL), American Airlines Group Inc. (AAL), FedEx Corporation (FDX) at Insider Monkey
May-22-15 09:30AM  The Zacks Analyst Blog Highlights: Kansas City Southern, Union Pacific, Norfolk Southern, CSX and American Airlines Group - Press Releases
May-21-15 03:43PM  Railroad Stocks in Trouble Over Lower Coal Shipments? - Analyst Blog
03:27PM  Transports running on fumes?
May-20-15 04:44PM  5 Things Union Pacific Wants You to Know at Investopedia
12:32PM  Union Pacific Cites Continuing Slide in Coal Shipments at The Wall Street Journal
11:30AM  UNION PACIFIC CORP Files SEC form 8-K, Regulation FD Disclosure
May-18-15 06:01AM  What is Your Investment Philosophy Based On?
May-16-15 08:38AM  10 things railroads wont tell you at MarketWatch
May-15-15 04:33PM  Will Uncertain Energy Markets Spell Trouble for Railroads? - Analyst Blog
03:24PM  Transports run out of steam: Pro
02:58PM  UNION PACIFIC CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
11:50AM  Amazon.com, Inc. (AMZN), Facebook Inc (FB): Top New Buys of Billionaire Jim Simons RenTech at Insider Monkey
11:21AM  Freight train carrying gravel derails south of San Antonio
07:05AM  Coal Shipments Rise after Falling for 2 Straight Weeks
May-14-15 11:30AM  Union Pacific (UNP) Stock Falls After Kansas City Southern Withdraws 2015 Guidance at TheStreet
10:30AM  Union Pacific Corporation Declares Second Quarter Dividend PR Newswire
May-13-15 02:00PM  Union Pacific Railroad Recognized for Superior Service by Hyundai GLOVIS PR Newswire
01:04PM  Jim Cramer -- Railroads, Retailers Holding the Market Down at TheStreet
09:00AM  Union Pacific Corporation CFO Rob Knight to Address Wolfe Research 8th Annual Global Transportation Conference PR Newswire
May-11-15 06:02AM  Economic Recovery is at Hand...Really!
May-07-15 05:08PM  Union Pacific Railroad Receives Logistics Excellence Awards from Toyota Logistics Services at noodls
May-06-15 06:50PM  Union Pacific Railroad Invests More Than $12 Million to Strengthen Missouri's Transportation Infrastructure at noodls
11:54AM  Union Pacific Plans to Invest Nearly $102 Million in its Nebraska Rail Infrastructure at noodls
09:30AM  The Zacks Analyst Blog Highlights: United Parcel Service, J.B. Hunt, Union Pacific, iShares Dow Jones Transportation Average Fund and SPDR S&P Transportation ETF - Press Releases
12:29AM  Lennar Bets on Silicon Valleys Spread at The Wall Street Journal
May-05-15 04:23PM  Union Pacific Plans to Invest $66 Million in its Missouri Rail Infrastructure at noodls
02:55PM  Skylands Capitals top 5 holdings at MarketWatch
11:12AM  Union Pacific Plans to Invest Nearly $41 Million in its Colorado Rail Infrastructure at noodls
08:30AM  Transport Leading Q1 Earnings Growth: Are ETFs Too? - ETF News And Commentary
08:30AM  Lennar Bets on Silicon Valley's Spread at The Wall Street Journal
May-04-15 04:24PM  Union Pacific Railroad Invests Nearly $8 Million to Strengthen Illinois' Transportation Infrastructure at noodls
11:47AM  Union Pacific Plans to Invest More Than $109 Million in its Iowa Rail Infrastructure at noodls
08:01AM  REPEAT-North American rail industry angered by new brake rule Reuters
07:30AM  Corporate America's Unleash-the-Drones Plea Puts the Heat on FAA
06:01AM  Markets Take A Stutter Step Forward
May-02-15 12:00AM  Research Reports at Barrons.com
May-01-15 08:00PM  Berkshire Starts 2015 on a More Solid Note at Morningstar
05:41PM  North American rail industry angered by new brake rule Reuters
05:39PM  Union Pacific Foundation Grants $25,000 to Four Montana Nonprofit Organizations at noodls
05:39PM  Union Pacific Announces Fremont, Calif., Land Sale at noodls
05:24PM  UNION PACIFIC CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
05:15PM  Union Pacific Announces Fremont, Calif. Land Sale PR Newswire
11:55AM  Latest 'fix' for California drought: Water by rail at CNBC
Apr-30-15 11:17AM  Union Pacific Plans to Invest $119 Million in its Illinois Rail Infrastructure at noodls
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates railroads in the United States. The company offers freight transportation services for agricultural products, including grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals consisting of industrial chemicals, plastics, crude oil, liquid petroleum gases, fertilizers, soda ash, sodium products, and phosphorus rock and sulfur products. It also provides transportation services for coal and petroleum coke; industrial products comprising construction products, minerals, consumer goods, metals, lumber, paper, and other miscellaneous products; and intermodal import and export containers and trailers. Its rail network includes 31,974 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and eastern United States gateways. Union Pacific Corporation was founded in 1862 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scott Cameron AEVP OPSMay 22Option Exercise57.372,770158,91550,635May 26 04:30 PM
DUREN DIANE KEVP & CORPORATE SECRETARYMay 22Sale104.3915,5001,618,057124,012May 22 03:41 PM
Scott Cameron AEVP OPSMay 22Sale104.442,770289,29947,865May 26 04:30 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCFeb 24Option Exercise24.254,00097,000102,528Feb 26 11:01 AM
FRITZ LANCE MPRESIDENT & CEOFeb 13Option Exercise57.3754,9723,153,744273,361Feb 17 07:56 PM
KORALESKI JOHN JCHAIRMAN OF THE BOARDFeb 13Option Exercise57.3760,7263,483,851321,766Feb 17 06:24 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCFeb 05Sale122.252,536310,02698,528Feb 09 05:58 PM
THAL GAYLA LSVP LAW & GEN COUNSELDec 22Sale120.007,594911,280107,686Dec 23 05:41 PM
MCCONNELL MICHAEL WDirectorNov 21Option Exercise14.7812,200180,31624,880Nov 24 07:34 PM
MCCONNELL MICHAEL WDirectorNov 21Sale121.8012,2001,485,90112,680Nov 24 07:34 PM
KNIGHT ROBERT M JREVP FINANCE & CFO UPCNov 21Sale122.0115,0001,830,150288,616Nov 24 06:36 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCSep 17Sale108.752,021219,78455,472Sep 18 10:28 AM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCSep 17Sale108.753,867420,536105,914Sep 18 10:28 AM
ROGEL STEVEN RDirectorSep 08Option Exercise14.7812,200180,31616,200Sep 09 04:14 PM
ROGEL STEVEN RDirectorSep 08Sale107.5312,2001,311,8294,000Sep 09 04:14 PM
HOPE RICHARDS JUDITHDirectorSep 03Option Exercise14.7812,200180,31627,740Sep 05 12:28 PM
HOPE RICHARDS JUDITHDirectorSep 03Sale106.446,200659,92821,540Sep 05 12:28 PM
DUREN DIANE KEVP & CORPORATE SECRETARYAug 29Option Exercise54.6331,3481,712,610145,756Sep 02 01:11 PM
DUREN DIANE KEVP & CORPORATE SECRETARYAug 29Sale105.0431,3483,292,716131,410Sep 02 01:11 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCJul 16Sale101.752,021205,63757,493Jul 17 05:49 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCJul 16Sale101.753,867393,467109,781Jul 17 05:49 PM
BIIB Biogen Inc. daily Stock Chart
BIIB [NASD]
Biogen Inc.
IndexS&P 500 P/E29.22 EPS (ttm)13.85 Insider Own0.10% Shs Outstand235.23M Perf Week-1.00%
Market Cap95.18B Forward P/E20.82 EPS next Y19.43 Insider Trans-22.50% Shs Float235.00M Perf Month5.28%
Income3.28B PEG1.73 EPS next Q4.06 Inst Own92.30% Short Float1.10% Perf Quarter-2.13%
Sales10.13B P/S9.40 EPS this Y58.40% Inst Trans0.00% Short Ratio1.66 Perf Half Y18.31%
Book/sh49.65 P/B8.15 EPS next Y16.39% ROA23.30% Target Price476.38 Perf Year22.19%
Cash/sh9.15 P/C44.23 EPS next 5Y16.84% ROE30.90% 52W Range290.85 - 480.18 Perf YTD19.20%
Dividend- P/FCF29.38 EPS past 5Y29.90% ROI26.20% 52W High-15.73% Beta0.94
Dividend %- Quick Ratio2.30 Sales past 5Y17.30% Gross Margin88.10% 52W Low39.12% ATR8.31
Employees7550 Current Ratio2.70 Sales Q/Q20.00% Oper. Margin43.20% RSI (14)55.27 Volatility2.17% 1.95%
OptionableYes Debt/Eq0.05 EPS Q/Q72.80% Profit Margin32.40% Rel Volume0.76 Prev Close404.28
ShortableYes LT Debt/Eq0.05 EarningsJul 23 BMO Payout0.00% Avg Volume1.56M Price404.63
Recom2.20 SMA201.39% SMA502.37% SMA2009.12% Volume1,188,779 Change0.09%
Jun-11-15Reiterated Leerink Partners Outperform $532 → $512
Jun-09-15Initiated Guggenheim Neutral
Apr-27-15Reiterated UBS Neutral $350 → $422
Apr-27-15Reiterated Argus Buy $440 → $450
Mar-23-15Downgrade Stifel Buy → Hold
Feb-02-15Reiterated Argus Buy $385 → $440
Jan-30-15Reiterated RBC Capital Mkts Outperform $400 → $445
Jan-30-15Reiterated Deutsche Bank Buy $430 → $460
Oct-22-14Upgrade Robert W. Baird Neutral → Outperform $374 → $382
Aug-19-14Resumed Stifel Buy $376
Jul-29-14Reiterated Argus Buy $360 → $385
Jul-24-14Reiterated UBS Neutral $330 → $354
Jul-09-14Reiterated RBC Capital Mkts Outperform $325 → $375
Mar-19-14Reiterated Stifel Buy $360 → $376
Mar-07-14Reiterated Barclays Overweight $325 → $352
Mar-03-14Reiterated Stifel Buy $330 → $360
Jan-30-14Reiterated UBS Neutral $300 → $310
Jan-30-14Reiterated Brean Capital Buy $293 → $377
Jan-30-14Reiterated Argus Buy $310 → $360
Jan-28-14Reiterated Deutsche Bank Buy $340 → $415
Jul-06-15 08:51PM  Biogen to Report Second Quarter 2015 Financial Results on July 24, 2015 Business Wire
03:58PM  Forget Biogen (BIIB), Buy These 3 Biotechnology Stocks Instead - Stocks in the News
03:05PM  Are Patent Challenges Paying Off For Kyle Bass?
09:50AM  Healthcare Stocks Likely to Outperform despite Rate Hike
07:51AM  Biogen Collaboration With Applied Genetic Is 'Interesting,' But Morgan Stanley Will Wait For More Data
07:00AM  Competition Rising for Baxalta at Morningstar
Jul-03-15 02:00PM  Applied Genetic Up on Biogen Deal for Eye Disease Drugs - Analyst Blog
12:30PM  What You May Have Missed In Biotech: Celgene's $1B Bet On Cancer Immunotherapy, And A New CF Drug at Forbes
Jul-02-15 05:05PM  Xoom Zooms, Teladoc Sinks a Day After Debut -- Tech Winners and Losers at TheStreet
03:30PM  Biogen: Where Did That Come From? at Barrons.com
03:27PM  Applied Genetic Technologies (AGTC) Stock Climbs on $124 Million Biogen Deal at TheStreet
12:57PM  Why Applied Genetic Technologies Corporation Stock Jumped Today at Motley Fool
12:48PM  Biogen to Pay Applied Genetic $124 Million to Develop Eye-Disease Treatments at The Wall Street Journal
12:02PM  Thursday's Mid-Day Movers: Real Good Solar, Xoom, ConforMIS, Health Net And More
11:28AM  Biogen, AGTC Link Up To Develop Gene Therapy at Investor's Business Daily
11:12AM  Biogen deal pushes tiny companys stock up by double digits at MarketWatch
10:01AM  Biogen enters eye-treatment arena with AGTC deal
09:54AM  Biogen Opens Gene Therapy Partnership Worth About $1 Billion at Bloomberg
07:01AM  AGTC to Host Conference Call and Webcast to Discuss Biogen Collaboration GlobeNewswire
07:00AM  Biogen and AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology Business Wire
Jul-01-15 07:15AM  Biogen Invests in the Greater Zurich Area: Biopharmaceutical Plant in the Canton of Solothurn Planned PR Newswire
Jun-30-15 06:36PM  U.S. doctors, hospitals reap $6.5 bln from drug and device makers -report Reuters
02:43PM  Why is Celgene So Darn Expensive? at Barrons.com
10:58AM  Why Alexion Stock Could Rip
Jun-29-15 04:35PM  Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog
12:55PM  Four ways that Biogen is being a good corporate citizen at bizjournals.com
09:05AM  3 Stocks to Buy if Biotech Crashes at Motley Fool
Jun-26-15 02:00AM  Biogen and Sobi Announce European Medicines Agency Validates ALPROLIX® (rFIXFc) Marketing Authorization Application Business Wire
Jun-25-15 07:50AM  Short Sellers Get More Selective on Big Biotech at 24/7 Wall St.
Jun-24-15 05:19PM  Does a Safe Biotechnology Stock Exist? at Investopedia
Jun-23-15 05:02PM  Veteran Investor Sam Isaly Picks Top Biotechs at Barrons.com
03:45PM  Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog
01:16PM  On the move: New hires and job transitions in the local life science industry at bizjournals.com
12:30PM  Biogen Achieves Carbon Neutrality Business Wire
12:10PM  Perrigo Going Up With Or Without Mylan, Says BMO at Investor's Business Daily
Jun-22-15 11:57PM  In middle of MS battle, pioneering foundation closing its doors at bizjournals.com
Jun-20-15 04:00PM  These are the Fortune 500s fastest-growing pharma companies at Fortune
Jun-19-15 03:44PM  Biotech bargain bin
03:19PM  Biotech to break out, buy these names: Analyst at CNBC
02:02PM  Why Biogen Is Inches Away From Changing the World
11:45AM  Report: Big Pharma is getting more worried about drug price pushback at bizjournals.com
Jun-18-15 05:40PM  Biotech's big boost
02:54PM  Biotech ETF Hits Record: How Much Higher Can It Go? at Barrons.com
08:00AM  Biogen and SELF Help Women Reimagine Daily Life with Relapsing Multiple Sclerosis (RMS) PR Newswire
07:30AM  New Biogen Hemophilia Data At ISTH Congress to Highlight Extension Study Outcomes and Pediatric Use Business Wire
Jun-17-15 04:06PM  The Note Moving Pharma Giants Today
Jun-16-15 07:33PM  3 Reasons That Biogen's Shares Could Rise at Investopedia
08:02AM  Top Health Care Funds: Can Outperformance Continue? at Investor's Business Daily
Jun-15-15 08:23AM  Quartet of GSK cast-off drugs soar to a combined value of $5bn at Financial Times
Jun-12-15 02:20PM  Isis Pharmaceuticals Up on Positive Data on ISIS-SMNRx - Analyst Blog
01:43PM  Why Gilead May be the Strongest Company in the World
09:51AM  Edited Transcript of BIIB shareholder or annual meeting 10-Jun-15 1:00pm GMT
07:57AM  Big Biotech Stocks See Declining Short Interest
Jun-11-15 08:05PM  Biogen's Biosimilars Program Leaps Forward at Investopedia
04:42PM  BIOGEN INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securit
01:36PM  Highlights From ISIS Pharmaceuticals At Goldman Sachs Healthcare Conference
12:58PM  Isis, Biogen Rare-Disease Drug Aids Infant Survival at Investor's Business Daily
Jun-10-15 11:19AM  Hedge Funds Buying Biotech IPO Operated By Ex-Fund Manager
09:07AM  Comparing Vasco Data Security Internationals Forward PE with QQQ
07:55AM  Short Sellers Lose Some Conviction Against Big Biotech at 24/7 Wall St.
06:00AM  Biogen and Samsung Bioepis Announce New Data for Three Anti-TNF Biosimilar Development Candidates at EULAR 2015 Congress Business Wire
Jun-09-15 08:47AM  Coverage initiated on Biogen by Guggenheim
07:36AM  Roche Takes Another Shot at Alzheimer's After Biogen Success
12:00AM  Roche Takes Another Shot at Alzheimers After Biogen Has Success at Bloomberg
Jun-08-15 03:56PM  Biotech company with RTP roots named No. 1 'green' company by Newsweek at bizjournals.com
Jun-04-15 07:00PM  Cramer: This blue stock is red hot
09:10AM  The Secret to Safely Investing in Biotech at Kiplinger
Jun-03-15 02:40PM  Choate adds former in-house counsel from Boston biotech giant at bizjournals.com
Jun-02-15 02:35PM  Whats so special about specialty drugs? at bizjournals.com
10:40AM  How Does Biogen Make its Money? at Investopedia
May-29-15 03:04PM  How To Avoid Investor Traps And Invest During Turbulent Times at Forbes
11:51AM  This stock is no longer in the Top 20 most held at CNBC
May-28-15 04:01PM  Biogen 2015 Annual Shareholder Meeting Webcast Business Wire
02:59PM  Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in ... Gurufocus
08:25AM  Short Sellers Get Even More Ambitious Against Biotech Leaders at 24/7 Wall St.
May-27-15 07:36PM  PRIMECAP Sells Portions of Its Top Two Stakes
May-26-15 03:30PM  A Sell in May Strategy at Forbes
May-22-15 02:45PM  A Beautiful Biotech Summer? at Barrons.com
May-21-15 02:20PM  BlueBird Bio: Another Biogen Rout In The Making?
01:06PM  Jim Cramer Answers Your Twitter Questions on Tesla, Jarden, Williams-Sonoma, Wayfair at TheStreet
May-20-15 04:01PM  Biogen to Present at Bernsteins 31st Annual Strategic Decisions Conference Business Wire
May-19-15 04:44PM  3 Things Biogen's Management Wants You to Know at Investopedia
03:39PM  Value plays in health care, financials & tech
01:36PM  Good year for stock pickers: Pro
01:06PM  Healthcare Mid-Day Winners and Losers: May 19, 2015
09:39AM  Billionaire Stanley Druckenmillers Top Value Picks Include Illumina, Inc. (ILMN), Biogen Inc (BIIB), LyondellBasell Industries NV (LYB) at Insider Monkey
08:33AM  3 Best Biotech Stocks to Add to Your Portfolio at TheStreet
May-18-15 08:03AM  Is the Stock Market Due for a Correction?
May-15-15 08:37AM  The Morning Download: Hardware Advances Bring Deep Learning, Real-Time Analytics Closer to Enterprise at The Wall Street Journal
May-14-15 06:11PM  Fidelity Adds to Biogen, Amazon and Sells Microsoft, Amex at Bloomberg
04:42PM  Buy Microsoft, Biogen for Performance, Avoid Consumer Discretionary Stocks at TheStreet
12:31PM  Biogen Promotes Former Dell Exec as CIO to 'Drive Innovation' at The Wall Street Journal
May-13-15 04:01PM  Biogen to Present at the 2015 UBS Global Healthcare Conference Business Wire
09:40AM  3 Biotech Stocks See Growing Short Interest
07:30AM  Biogen Names Matt Griffiths as Chief Information Officer Business Wire
May-12-15 08:05AM  Short Sellers Start to Get Nervous on Biotech at 24/7 Wall St.
May-11-15 09:59PM  Is This Biogen's Next Billion-Dollar Blockbuster? at Investopedia
May-08-15 11:41AM  Biogen Announces Massive $5 Billion Stock Repurchase Program: Share Value To Go Up
07:47AM  Early movers: AOL, WHR, PM, CBS, NOK & more at CNBC
May-07-15 06:28PM  Biogen says it will buy back up to $5B in stock
Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It provides AVONEX to treat relapsing multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohn's disease; PLEGRIDY to treat relapsing MS; TECFIDERA to treat MS; FAMPYRA to improve walking in adult patients with MS; ALPROLIX to treat hemophilia B; ELOCTATE to treat hemophilia A; RITUXAN for treating non-Hodgkin's lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia (CLL), as well as two forms of ANCA-associated vasculitis; GAZYVA for the treatment of patients with previously untreated CLL; and FUMADERM to treat severe plaque psoriasis in adult patients. The company's products that completed Phase III clinical trials comprise ZINBRYTA, a monoclonal antibody in relapsing MS. Its products under Phase III clinical trials consist of TYSABRI for secondary progressive MS and spinal muscular atrophy; ISIS SMN for spinal muscular atrophy; and GAZYVA for non-Hodgkin's lymphoma. The company's Phase II clinical trial products include Anti-LINGO for optic neuritis and MS; Neublastin for neuropathic pain; TYSABRI for optic neuritis; ANTI-TWAEK for lupus nephritis; BAN2401 and E2609 for Alzheimer's disease; and GAZYVA for lupus nephritis, as well as Phase IIa clinical trial products include STX-100 for idiopathic pulmonary fibrosis. Its Phase I clinical trial products comprise BIIB037 for Alzheimer's disease; ISIS DMPK for myotonic dystrophy; BIIB061 for MS; and Anti-BDCA2 for systemic lupus erythematosus, as well as Phase Ib clinical trial products include BIIB037 for Alzheimer's disease and Anti-C for systemic lupus erythematosus. The company was formerly known as Biogen Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1985 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Posner Brian SDirectorJun 22Sale415.00470195,0505,275Jun 23 04:14 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentJun 19Sale410.003,8411,574,81011,817Jun 22 04:15 PM
Posner Brian SDirectorJun 15Sale386.64400154,6565,745Jun 16 06:54 PM
Koppel AdamSVP, Chief Strategy OfficerJun 02Option Exercise0.002,38402,514Jun 04 05:49 PM
SCANGOS GEORGE AChief Executive OfficerJun 01Sale398.871,362543,26141,090Jun 02 04:10 PM
COVINO GREGORY FVP, Chief Accounting OfficerMay 01Option Exercise386.22347134,0181,874May 05 04:36 PM
SCANGOS GEORGE AChief Executive OfficerMay 01Sale377.521,362514,18242,452May 05 04:34 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerApr 02Option Exercise0.0097502,134Apr 03 04:24 PM
SCANGOS GEORGE AChief Executive OfficerApr 01Sale423.201,362576,39843,814Apr 02 04:29 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerMar 27Sale430.12430184,9528,574Mar 30 04:13 PM
Cox JohnEVP Pharmaceutical Oper & TechMar 25Option Exercise65.855,066333,57137,577Mar 26 04:31 PM
Cox JohnEVP Pharmaceutical Oper & TechMar 25Sale449.0612,0105,393,21125,567Mar 26 04:31 PM
Rowinsky Eric KDirectorMar 20Option Exercise59.8211,667697,92022,977Mar 23 04:33 PM
Rowinsky Eric KDirectorMar 20Sale475.0011,6675,541,82511,310Mar 23 04:33 PM
Rowinsky Eric KDirectorMar 19Option Exercise59.822,333139,56013,643Mar 20 05:03 PM
Rowinsky Eric KDirectorMar 19Sale436.142,3331,017,50811,310Mar 20 05:03 PM
Rowinsky Eric KDirectorMar 17Option Exercise59.824,667279,18015,977Mar 18 05:03 PM
Rowinsky Eric KDirectorMar 17Sale425.454,6671,985,58911,310Mar 18 05:03 PM
DiPietro KennethEVP Human ResourcesMar 16Sale415.46803333,6140Mar 17 08:10 PM
SCANGOS GEORGE AChief Executive OfficerMar 13Sale412.69537221,61345,176Mar 16 08:39 PM
SHERWIN STEPHEN ADirectorMar 10Option Exercise59.826,000358,92010,150Mar 11 04:17 PM
PANGIA ROBERT WDirectorMar 10Option Exercise47.713,625172,95417,998Mar 11 04:13 PM
PANGIA ROBERT WDirectorMar 10Sale413.403,6251,498,57814,873Mar 11 04:13 PM
SHERWIN STEPHEN ADirectorMar 10Sale409.676,0002,458,0204,150Mar 11 04:17 PM
Rowinsky Eric KDirectorMar 09Option Exercise59.824,666279,12015,976Mar 11 04:15 PM
Rowinsky Eric KDirectorMar 09Sale417.234,6661,946,79511,310Mar 11 04:15 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerMar 02Sale409.493,1741,299,7159,004Mar 03 04:44 PM
SCANGOS GEORGE AChief Executive OfficerMar 02Sale410.67825338,80345,713Mar 03 04:39 PM
SCANGOS GEORGE AChief Executive OfficerFeb 19Sale401.04537215,35846,538Feb 20 04:28 PM
SCANGOS GEORGE AChief Executive OfficerFeb 17Sale389.11825321,01647,075Feb 18 04:45 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 17Sale389.112,128828,0264,321Feb 18 04:41 PM
DiPietro KennethEVP Human ResourcesFeb 17Sale389.111,188462,263803Feb 18 04:37 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 17Sale389.11418162,64815,004Feb 18 04:36 PM
SCANGOS GEORGE AChief Executive OfficerFeb 12Option Exercise0.0015,599045,547Feb 17 09:32 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 12Option Exercise0.0047101,450Feb 17 09:16 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 12Option Exercise0.003,63407,152Feb 17 08:54 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerFeb 12Option Exercise0.001,20101,318Feb 17 08:50 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 12Option Exercise0.001,605015,805Feb 17 08:47 PM
Clancy Paul JExecutive VP and CFOFeb 12Option Exercise0.004,299022,960Feb 17 08:44 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 12Option Exercise0.003,738033,214Feb 17 08:40 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 12Option Exercise0.005,200016,481Feb 17 08:37 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 12Option Exercise0.003,769028,634Feb 17 08:34 PM
DiPietro KennethEVP Human ResourcesFeb 12Option Exercise0.003,76402,706Feb 17 08:30 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 12Option Exercise0.003,60108,771Feb 17 08:26 PM
SCANGOS GEORGE AChief Executive OfficerFeb 10Option Exercise0.0018,833043,148Feb 11 04:25 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 10Sale398.111,143455,03914,574Feb 11 04:26 PM
Clancy Paul JExecutive VP and CFOFeb 09Option Exercise0.004,691022,194Feb 10 05:06 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 09Option Exercise0.004,691032,744Feb 10 05:07 PM
SCANGOS GEORGE AChief Executive OfficerFeb 09Option Exercise0.0011,270029,255Feb 11 04:25 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 09Option Exercise0.001,82407,088Feb 10 05:08 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 09Option Exercise0.001,824016,398Feb 10 05:11 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 09Option Exercise0.003,909027,716Feb 10 05:12 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 09Sale398.05856340,73114,574Feb 10 05:11 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 08Option Exercise0.002,498024,625Feb 10 05:12 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 08Option Exercise0.001,277015,851Feb 10 05:11 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 08Option Exercise0.002,70505,802Feb 10 05:10 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 08Option Exercise0.002,63606,147Feb 10 05:08 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 08Option Exercise0.003,468014,542Feb 10 05:14 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 08Option Exercise0.004,023029,590Feb 10 05:07 PM
Clancy Paul JExecutive VP and CFOFeb 08Option Exercise0.003,191018,646Feb 10 05:06 PM
DiPietro KennethEVP Human ResourcesFeb 02Sale389.031,656644,2340Feb 03 06:35 PM
DiPietro KennethEVP Human ResourcesFeb 01Option Exercise0.002,46302,463Feb 02 07:46 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 01Option Exercise0.005,157013,133Feb 02 07:43 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 01Option Exercise0.005,15705,157Feb 02 07:40 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerDec 15Sale346.501,981686,417352Dec 16 04:36 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerDec 04Sale345.88440152,18714,574Dec 05 05:20 PM
Holtzman Steven HEVP Corporate DevelopmentDec 02Sale335.651,749587,0520Dec 03 04:32 PM
Holtzman Steven HEVP Corporate DevelopmentNov 11Sale330.001,750577,5001,749Nov 12 04:24 PM
SCANGOS GEORGE AChief Executive OfficerNov 03Sale320.781,128361,84017,985Nov 04 04:18 PM
SCANGOS GEORGE AChief Executive OfficerOct 01Sale330.971,127373,00319,113Oct 02 04:44 PM
Holtzman Steven HEVP Corporate DevelopmentOct 01Sale330.971,750579,1983,499Oct 02 04:42 PM
SCANGOS GEORGE AChief Executive OfficerSep 02Sale345.471,128389,69020,240Sep 04 04:15 PM
SCANGOS GEORGE AChief Executive OfficerAug 01Sale332.931,128375,54521,368Aug 04 04:43 PM
SCANGOS GEORGE AChief Executive OfficerJul 16Sale312.3712,3163,847,14922,496Jul 18 05:59 PM
SCANGOS GEORGE AChief Executive OfficerJul 15Option Exercise0.0021,339044,874Jul 17 04:45 PM
UNH UnitedHealth Group Incorporated daily Stock Chart
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E20.36 EPS (ttm)6.00 Insider Own0.80% Shs Outstand951.90M Perf Week-0.88%
Market Cap116.28B Forward P/E17.27 EPS next Y7.08 Insider Trans-1.08% Shs Float936.40M Perf Month5.17%
Income5.93B PEG2.07 EPS next Q1.59 Inst Own90.90% Short Float1.13% Perf Quarter4.23%
Sales134.52B P/S0.86 EPS this Y3.60% Inst Trans0.15% Short Ratio2.56 Perf Half Y22.14%
Book/sh33.42 P/B3.66 EPS next Y13.00% ROA6.80% Target Price141.10 Perf Year48.86%
Cash/sh9.09 P/C13.44 EPS next 5Y9.82% ROE18.30% 52W Range77.52 - 124.11 Perf YTD21.76%
Dividend2.00 P/FCF19.63 EPS past 5Y12.00% ROI12.50% 52W High-1.57% Beta0.59
Dividend %1.64% Quick Ratio0.70 Sales past 5Y8.40% Gross Margin- 52W Low57.58% ATR2.44
Employees170000 Current Ratio0.70 Sales Q/Q12.80% Oper. Margin8.10% RSI (14)56.98 Volatility1.99% 1.94%
OptionableYes Debt/Eq0.58 EPS Q/Q30.40% Profit Margin4.40% Rel Volume1.58 Prev Close121.81
ShortableYes LT Debt/Eq0.49 EarningsJul 16 BMO Payout24.80% Avg Volume4.12M Price122.16
Recom1.70 SMA201.73% SMA503.48% SMA20014.88% Volume6,517,842 Change0.29%
Jun-26-15Upgrade Sterne Agee CRT Neutral → Buy
Jun-24-15Initiated RBC Capital Mkts Outperform $159
Apr-17-15Reiterated Oppenheimer Outperform $128 → $133
Apr-17-15Initiated Mizuho Buy $140 → $146
Apr-07-15Reiterated Deutsche Bank Buy $131 → $133
Mar-31-15Reiterated FBR Capital Outperform $120 → $130
Mar-31-15Initiated FBR Capital Outperform $120 → $130
Mar-25-15Initiated Mizuho Buy $140
Mar-06-15Reiterated Deutsche Bank Buy $119 → $127
Jan-22-15Reiterated Oppenheimer Outperform $108 → $115
Jan-08-15Reiterated UBS Buy $111 → $121
Dec-03-14Reiterated Stifel Buy $95 → $110
Dec-03-14Reiterated Oppenheimer Outperform $94 → $108
Dec-03-14Reiterated FBR Capital Outperform $95 → $110
Jul-18-14Reiterated Oppenheimer Outperform $84 → $94
Jul-18-14Reiterated Deutsche Bank Buy $92 → $95
Jul-18-14Reiterated Barclays Overweight $84 → $99
Jul-17-14Reiterated FBR Capital Outperform $85 → $95
Apr-21-14Reiterated Deutsche Bank Buy $90 → $85
Apr-21-14Reiterated CRT Capital Buy $80 → $90
Jul-06-15 04:30PM  Jack Levy's Swan Song: Selling Humana at The Wall Street Journal
04:00PM  Stocks close mildly lower despite Greece; oil plunge weighs on energy at CNBC
03:52PM  Dow dips on Greece concerns; energy sector fizzles at CNBC
01:10PM  Megamergers could reshape health insurance marketplace (Video) at bizjournals.com
10:45AM  Health Insurance Mergers Falling Into Place at 24/7 Wall St.
10:40AM  How To Trade Five Dow Stocks That Are Above Key Moving Averages at Forbes
10:23AM  With Merger Deal, Aetna, Humana Get Ahead of the Pack at The Wall Street Journal
06:00AM  Insurance mergers getting hot
12:18AM  With Merger Deal, Aetna, Humana Get Ahead of the Pack at The Wall Street Journal
Jul-05-15 08:03PM  Aetna, Humana Hurry to the Altar at The Wall Street Journal
10:18AM  Attention Investors: Drop Greek Dark Drama Worries, Focus On Enticing U.S. Market Opportunities at Forbes
Jul-03-15 10:20PM  Rivals Lurked Behind Aetna's Deal With Humana at The Wall Street Journal
05:55PM  UnitedHealthcare and Optum Act to Support People Affected by Wenatchee Wildfires Business Wire
08:30AM  Obamacare Prices Could Rise If Blue Cross Plans Face More Competition at Forbes
05:38AM  Aetna-Humana Adds to Takeover Frenzy Among U.S. Health Insurers
Jul-02-15 10:50PM  Obamacare cash fuels healthcare merger mania at Los Angeles Times
04:01PM  The 4 Stocks That Sank the Dow on Thursday at 24/7 Wall St.
12:15PM  Centene's $6.3B Health Net Deal Shows Medicaid Plans Quick To Diversify at Forbes
Jul-01-15 04:47PM  Health Care Bull Market Will Continue, Charts Say at Barrons.com
04:06PM  UNITEDHEALTH GROUP INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Right
01:37PM  Best play for rest of 2015
09:33AM  4 Health Care Stocks Poised for Growth
09:30AM  Zacks Industry Rank Analysis Highlights: UnitedHealth, Anthem, Aetna, Humana and Cigna - Press Releases
Jun-30-15 07:16PM  Lightning Round: It's time! This is too low at CNBC
06:03PM  IBD Market Wrap - 06/30/15
06:00PM  Cramer: A stock so bad I can't even say its name
05:12PM  How the Dow Jones industrial average fared on Tuesday
07:40AM  For Sens. Paul And McConnell, A Humana Sale Means More Obamacare Angst at Forbes
Jun-29-15 05:24PM  UnitedHealth Scales 52-Week High on Favorable ACA Ruling - Analyst Blog
01:32PM  Dow negative for the year
11:18AM  Five Dividend Stocks With Goliath Potential at Forbes
10:50AM  Do Health Insurance Mergers Really Need to Sweat DOJ Reviews? at 24/7 Wall St.
09:30AM  Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Aetna, Humana and Health Net - Press Releases
09:30AM  Zacks Industry Outlook Highlights: UnitedHealth Group, Aetna, Cigna, Humana and Anthem - Press Releases
Jun-28-15 05:32PM  DOJ Girds for Strict Scrutiny of Any Health-Insurer Mergers at The Wall Street Journal
09:12AM  The Supreme Court Saves Obamacare a Third Time, But Big Challenges Remain at Motley Fool
Jun-26-15 06:00PM  Domino's, UnitedHealth Clear Buy Points at Investor's Business Daily
02:28PM  UnitedHealth Group (UNH) Stock Continues to Rally After Obamacare Ruling at TheStreet
02:11PM  Health Insurers Shine in Obamacare Era - Industry Outlook
02:10PM  Health care stocks rally
01:56PM  Markets sailing into the wind: Pro
01:19PM  Leerink Sees Humana Takeout At $220/Share Or More
09:56AM  Nike News Pushes Against China, Greece - Ahead of Wall Street
09:43AM  Obamacare ruling greenlights Aetna-Humana dealmaking at Fortune
08:46AM  U.S. stock futures struggle to push higher at MarketWatch
08:18AM  Analysts' Actions -- Bed Bath & Beyond, Tenet, UnitedHeath and More
06:46AM  UnitedHealth upgraded by Sterne Agee CRT
06:18AM  Sell Aetna, Anthem, 5 Others on Jump from Supreme Court's 'Obamacare' Ruling at TheStreet
Jun-25-15 05:29PM  3 Industry Groups To Watch After ObamaCare Ruling at Investor's Business Daily
03:04PM  Supreme Court decision lifts health care
02:56PM  What Are Investors Saying About the Obamacare Ruling? - Analyst Blog
02:38PM  4 Managed Health Care Stocks to Buy Following Obamacare Ruling at TheStreet
02:32PM  Supreme Court Upholds Obamacare Subsidies, Health Stocks Jump - Stocks in the News
02:14PM  Merrill Lynch Investment Manager Likes Health Care, Consumer Stocks at TheStreet
02:00PM  Report: Aetna close to buying Humana
01:55PM  One Factor Driving UnitedHealth Group (UNH) Stock Higher at TheStreet
01:09PM  Supreme Court Backstops ObamaCare Again: Now What? - Analyst Blog
12:05PM  Health Care Stocks Jump On Supreme Court Decision; Indexes Crawl Higher at Investor's Business Daily
11:53AM  Hospital stocks leap after Supreme Court backs overhaul
11:40AM  Supreme Court Ruling a Bigger Boost for Hospitals than Insurers at Barrons.com
11:40AM  Cashin says: Health care ruling sparks rally
10:53AM  The Obamacare Trade: How Stocks Are Reacting to the Supreme Court Ruling at The Wall Street Journal
10:42AM  Health care stocks surge on Obamacare ruling at CNBC
10:15AM  Positive decision for healthcare facility stocks: Pro
10:12AM  High court backs White House on health law
10:07AM  Is Anthem Paying Up for Cigna?
09:30AM  Zacks Industry Outlook Highlights: CIGNA, Anthem, Humana, Health Net and UnitedHealth Group - Press Releases
05:00AM  As a merger wave swells, companies dare the government to stop them
Jun-24-15 07:55PM  Sacramento-Area Doctors Offices and Health Clinics Receive Reading Stations and Childrens Books to Encourage Reading and Healthy Living Among Children Business Wire
04:01PM  The 4 Stocks That Sank the DJIA on Wednesday at 24/7 Wall St.
02:49PM  King v. Burwell: Fix Obamacare's Job Killing Tax Credits at Forbes
01:38PM  M&A Activity Stokes Inflows to Healthcare Providers ETFs
01:35PM  Matthew Tewksbury Unlocked Joel Greenblatts Magic Formula at Insider Monkey
10:06AM  Forget the Dow 30. These Days, It's the Dow 10. at The Wall Street Journal
04:17AM  King v. Burwell Obamacare Enrollees To States: Don't Set Up ACA Exchanges at Forbes
Jun-23-15 06:43PM  Drug, Hospital M&A Spurs Big Insurers To Eye Mega-Deals
04:04PM  Cigna Corp Hits 52-Week High on Takeover Bid by Anthem - Analyst Blog
02:20PM  Here's why massive health insurance mergers might not be bad for business at bizjournals.com
01:31PM  These stocks will move when the Supreme Court rules on Obamacare
01:28PM  Stocks Dip As Facebook Breaks Out; Darden Restaurants Reverses Gains at Investor's Business Daily
01:22PM  UnitedHealth leaves insurance industry lobbying group AHIP Reuters
12:22PM  UnitedHealth Group Exits Trade Group at The Wall Street Journal
10:04AM  Presbyterian Healthcare Services and UnitedHealthcare Collaborate to Improve Patient Care in New Mexico Business Wire
09:53AM  Health Insurers Seen in Merger Race to Win Antitrust Approval at Bloomberg
08:02AM  ObamaCare Enables Health Insurer Merger Mania at Investor's Business Daily
08:00AM  Health Care Provider ETF in Focus on M&A Talks - ETF News And Commentary
07:00AM  UnitedHealth Group Schedules Second Quarter Results Earnings Release and Conference Call for July 16, 2015 Business Wire
06:00AM  Jim Cramer's Top Takeaways: UnitedHealth, Ambarella, Radius Health at TheStreet
Jun-22-15 08:29PM  Jim Cramer's 'Mad Money' Recap: Let the Good Stocks Shine at TheStreet
04:16PM  Humana Has Farthest to Fall If Frozen Out From Deals: Real M&A at Bloomberg
02:46PM  Anthem reaffirms commitment to its $47-billion bid for Cigna AP
12:10PM  Aetna & Humana: Here Comes the New Big Three? at Barrons.com
11:32AM  Shrink Obamacare's Costs By Removing Rule Driving Up Young People's Premiums at Forbes
11:09AM  Dow adds 150 points, Nasdaq sets intraday high on Greece hopes at CNBC
09:07AM  Will One of the Health Insurance Mergers Get a Cold Shoulder? at 24/7 Wall St.
08:33AM  The 6 Best Stocks to Buy in the Dow Jones Industrial Average at TheStreet
08:15AM  Merger fever hits health care sector
08:08AM  Embracing Risk While Waiting On Greece The Fat Lady at Investor's Business Daily
08:02AM  Traders buy the rumors of Greece, merger deals. Will they sell the news?
07:30AM  Ensuring a trade in UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company's UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. It also provides services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits. This segment serves through a network of 850,000 physicians and other health care professionals, and approximately 6,100 hospitals and other facilities. Its OptumHealth segment offers health management services, including care delivery, care management, consumer engagement, distribution, and health financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The company's OptumInsight segment provides software and information products, advisory consulting services, and business process outsourcing services to hospitals, physicians, commercial health plans, government agencies, life sciences companies, and other organizations. Its OptumRx segment offers pharmacy benefit management services and programs, including retail pharmacy network management, home delivery and specialty pharmacy, manufacturer rebate contracting and administration, benefit plan design and consultation, claims processing, and a range of clinical program services, such as formulary management and compliance, drug utilization review, and disease and drug therapy management services. The company was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BURKE RICHARD TDirectorJul 01Option Exercise52.8110,000528,1002,108,981Jul 02 05:02 PM
WILENSKY GAIL RDirectorJun 11Option Exercise59.2520,6201,221,79872,934Jun 15 04:16 PM
WILENSKY GAIL RDirectorJun 11Sale118.9720,6202,453,06452,314Jun 15 04:16 PM
BURKE RICHARD TDirectorMay 02Option Exercise48.3692044,4872,098,904May 04 05:19 PM
WILSON D ELLENEVP Human CapitalApr 20Option Exercise46.1816,275751,58068,160Apr 21 04:44 PM
WILSON D ELLENEVP Human CapitalApr 20Sale119.483,300394,28453,732Apr 21 04:44 PM
BURKE RICHARD TDirectorApr 01Option Exercise47.9210,000479,1502,097,664Apr 03 04:31 PM
BALLARD WILLIAM C JRDirectorMar 18Option Exercise52.8110,000528,10077,047Mar 20 05:23 PM
BALLARD WILLIAM C JRDirectorMar 18Sale120.4810,0001,204,77567,047Mar 20 05:23 PM
RANGEN ERIC SSr VP & Chief Acctg OfficerFeb 25Sale114.03923105,25011,697Feb 26 05:26 PM
RANGEN ERIC SSr VP & Chief Acctg OfficerFeb 20Option Exercise63.276,108386,44631,124Feb 24 05:31 PM
RANGEN ERIC SSr VP & Chief Acctg OfficerFeb 20Sale111.0316,2521,804,42912,620Feb 24 05:31 PM
WICHMANN DAVID SPresident & CFOFeb 17Option Exercise52.77165,0008,706,350606,191Feb 18 06:01 PM
BURKE RICHARD TDirectorJan 29Option Exercise45.3494042,6202,088,547Jan 30 04:56 PM
BURKE RICHARD TDirectorJan 29Sale108.15940101,6622,087,607Jan 30 04:56 PM
BALLARD WILLIAM C JRDirectorJan 26Option Exercise47.9210,000479,15077,047Jan 27 04:34 PM
BALLARD WILLIAM C JRDirectorJan 26Sale111.6610,0001,116,63867,047Jan 27 04:34 PM
WILENSKY GAIL RDirectorJan 22Option Exercise50.3820,8501,050,36272,787Jan 26 04:41 PM
Shine Kenneth IrwinDirectorJan 22Option Exercise25.1662515,72526,771Jan 26 04:40 PM
Shine Kenneth IrwinDirectorJan 22Sale112.8562570,53226,146Jan 26 04:40 PM
WILENSKY GAIL RDirectorJan 22Sale109.7520,8502,288,28851,937Jan 26 04:41 PM
HEMSLEY STEPHEN JChief Exec OfficerDec 18Option Exercise48.63850,00041,334,9513,225,829Dec 22 04:31 PM
LEATHERDALE DOUGLAS WDirectorNov 18Sale98.2410,000982,433938,325Nov 20 05:38 PM
BURKE RICHARD TDirectorOct 20Sale88.4950,0004,424,3902,112,165Oct 22 04:46 PM
BALLARD WILLIAM C JRDirectorOct 17Option Exercise43.3110,000433,10076,605Oct 20 05:35 PM
BALLARD WILLIAM C JRDirectorOct 17Sale87.5110,000875,10666,605Oct 20 05:35 PM
BURKE RICHARD TDirectorSep 17Sale87.03100,0008,703,4502,162,689Sep 19 04:19 PM
LEATHERDALE DOUGLAS WDirectorSep 16Sale87.164,800418,3488,000Sep 16 04:53 PM
LEATHERDALE DOUGLAS WDirectorSep 16Sale87.2411,000959,648947,809Sep 16 04:53 PM
BURKE RICHARD TDirectorSep 10Option Exercise40.0321,040842,3302,262,689Sep 11 04:28 PM
WILENSKY GAIL RDirectorAug 26Option Exercise43.3910,400451,23661,379Aug 27 04:21 PM
WILENSKY GAIL RDirectorAug 26Sale85.0010,400884,00050,979Aug 27 04:21 PM
LEATHERDALE DOUGLAS WDirectorAug 22Option Exercise50.2643,7602,199,322958,809Aug 25 05:30 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E21.47 EPS (ttm)1.37 Insider Own0.30% Shs Outstand1.99B Perf Week-2.52%
Market Cap58.59B Forward P/E19.34 EPS next Y1.52 Insider Trans380.54% Shs Float1.29B Perf Month-5.86%
Income2.62B PEG3.64 EPS next Q0.33 Inst Own32.30% Short Float0.72% Perf Quarter-10.22%
Sales42.51B P/S1.38 EPS this Y4.30% Inst Trans0.02% Short Ratio3.35 Perf Half Y-20.12%
Book/sh10.30 P/B2.86 EPS next Y12.42% ROA5.90% Target Price40.33 Perf Year-24.25%
Cash/sh0.04 P/C722.43 EPS next 5Y5.90% ROE15.10% 52W Range28.83 - 41.38 Perf YTD-18.55%
Dividend1.50 P/FCF- EPS past 5Y24.60% ROI9.50% 52W High-28.90% Beta0.74
Dividend %5.10% Quick Ratio0.60 Sales past 5Y13.50% Gross Margin8.40% 52W Low2.05% ATR0.63
Employees6900 Current Ratio0.80 Sales Q/Q-42.10% Oper. Margin8.00% RSI (14)30.70 Volatility2.78% 1.97%
OptionableYes Debt/Eq1.09 EPS Q/Q-25.60% Profit Margin6.20% Rel Volume0.82 Prev Close29.74
ShortableYes LT Debt/Eq1.02 EarningsJul 30 BMO Payout101.10% Avg Volume2.77M Price29.42
Recom1.60 SMA20-4.86% SMA50-9.12% SMA200-15.12% Volume2,279,339 Change-1.08%
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
May-02-14Reiterated Oppenheimer Outperform $74 → $86
Mar-20-14Reiterated Stifel Buy $70 → $75
Jan-31-14Reiterated Argus Buy $70 → $75
Jan-06-14Reiterated Deutsche Bank Buy $70 → $74
Aug-02-13Resumed Oppenheimer Outperform $67 → $71
Aug-02-13Reiterated Stifel Buy $64 → $68
Apr-19-13Reiterated Wunderlich Buy $61 → $66
Apr-18-13Reiterated Deutsche Bank Buy $68 → $70
Apr-15-13Reiterated Deutsche Bank Buy $65 → $68
Jan-11-13Reiterated Deutsche Bank Buy $60 → $62
May-03-12Reiterated UBS Buy $55 → $57
Apr-17-12Initiated Global Hunter Securities Accumulate $53
Feb-16-12Upgrade Argus Hold → Buy $61
Jul-06-15 06:14AM  Enterprise Products draws calls
Jul-03-15 08:10AM  US Adds a Dozen Oil Rigs, Reversing 6 Months of Declines at 24/7 Wall St.
Jul-02-15 06:03PM  Better Buy: Enterprise Products or Kinder Morgan at Investopedia
Jul-01-15 04:24PM  Enterprise Signs Additional Commitment for Aegis Ethane Pipeline Business Wire
Jun-29-15 07:53AM  Midstream MLPs: Who Were the Best Performers on June 26?
Jun-27-15 09:05AM  Total US Rig Count Rises as Oil Rigs Drop 3 at 24/7 Wall St.
Jun-25-15 11:56AM  Does it Make Sense to Have an MLP in an IRA? at Investopedia
Jun-22-15 04:27PM  Energy Transfer offer may be Williams' best option -analysts
12:40PM  Enterprise Products Partners Banks on Strategic Investments - Analyst Blog
12:37PM  June 19 MLP Losers: Genesis Energy, Crestwood Midstream Partners
09:09AM  Enterprise Products Partners to Participate in Credit Suisse MLP and Energy Logistics Conference Business Wire
Jun-20-15 08:25AM  Hedge Funds Cut Exposure to Oil as Drilling Rig Count Slips
Jun-16-15 02:46PM  7 Energy Stocks SunTrust Just Initiated On
08:40AM  Top Analyst Upgrades and Downgrades: Ally, Corning, Enterprise, Kinder Morgan, Twitter, Aerie Pharma and More at 24/7 Wall St.
07:21AM  Coverage initiated on Enterprise Products by Sun Trust Rbsn Humphrey
Jun-15-15 05:56PM  4 Midstream Energy Picks Bucking the Weak Trends at Barrons.com
Jun-11-15 03:33PM  3 MLP Picks with High Yields and New Deal Backlogs at Barrons.com
Jun-02-15 08:53PM  Enterprise Buys $2.1 Billion in Low-Hanging Fruit at Investopedia
02:40PM  Enterprise Purchases Eagle Ford Midstream Assets for $2.15B - Analyst Blog
09:40AM  Deals of the Day: Intel's Bold Move, Mylan Raises the Stakes at The Wall Street Journal
Jun-01-15 04:50PM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:49PM  Enterprise Buys Oil and Gas Pipelines in Texas for $2.15 Billion at The Wall Street Journal
11:05AM  Pioneer and Reliance selling joint business to Enterprise
10:45AM  Enterprise Resources To Buy Stakes In Midstream Unit at Investor's Business Daily
10:40AM  Enterprise Products Partners to buy Eagle Ford business for $2.15B at bizjournals.com
10:38AM  Pioneer Natural Resources announces $2.15B midstream sale at bizjournals.com
10:23AM  Enterprise Products to buy Eagle Ford pipeline for $2.15 bln
10:05AM  Analyzing How Williams Partners Segments Performed in 1Q15
09:18AM  Enterprise Products to buy midstream assets for $2.15 bln
09:01AM  Pioneer Natural Resources Announces Sale of Eagle Ford Shale Midstream Business for $2.15B
08:57AM  MORE: Enterprise Products to Buy Eagle Ford Assets for $2.15b at Bloomberg
08:53AM  Enterprise to Buy Eagle Ford Pipeline Unit for $2.15 Billion at Bloomberg
08:49AM  Enterprise Announces Acquisition of Eagle Ford Midstream Assets Business Wire
May-29-15 12:00AM  Preliminary Transcript of CSCO conference call or presentation 29-May-15 4:00pm GMT
12:00AM  Edited Transcript of CSCO conference call or presentation 29-May-15 4:00pm GMT
May-26-15 04:38PM  Wunderlich's Top Takeaways From The NAPTP Conference
May-22-15 08:45PM  Is Enterprise Product's Stock a Buy Today? at Investopedia
09:07AM  Enbridge can expand Canadian crude movements to US Gulf Coast-exec
May-20-15 04:10PM  Enterprise Products Partners to Participate in Master Limited Partnership Investor Conference Business Wire
08:33AM  Why Williams Partners Stock Dipped after Its 1Q15 Earnings
08:33AM  An Investors Guide to Williams Partners 1Q15 Performance
May-19-15 04:45PM  3 Reasons Enterprise Products Stock Could Rise at Investopedia
01:35PM  Enterprise Products Partners' Growth Projects Bode Well - Analyst Blog
09:06AM  Wall Street Recommendations for EPD after 1Q15 Earnings
May-18-15 12:38PM  Goldman's Energy Names To Buy And Sell
11:06AM  EPDs Onshore Natural Gas Pipelines & Services Segment
May-15-15 01:04PM  ENTERPRISE PRODUCTS PARTNERS L P Financials
11:02AM  EPDs Stock Sees Marginal Decrease after 1Q15 Earnings Release
11:02AM  An Investors Guide to EPDs 1Q15 Performance
May-14-15 04:09PM  What Are Enterpise Product Partners Key Operating Segments?
03:53PM  Enterprise Product Partners (EPD): A Leader in MLPs
May-11-15 05:43PM  Enterprise Products Partners to Participate in Investor Conferences Business Wire
May-09-15 10:45AM  9 Oil and Gas Stocks Analysts Want You to Buy Now at 24/7 Wall St.
May-08-15 11:24PM  5 Things Enterprise's Management Wants You to Know at Investopedia
09:02AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-Q, Quarterly Report
May-07-15 09:47AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financ
May-06-15 08:30AM  Salient Midstream & MLP Fund Announces Second Quarter 2015 Dividend of $0.367 per Share and Net Asset Value as of April 30, 2015 PR Newswire
May-05-15 11:25AM  Is the Return of $60 Crude Oil Here to Stay? at 24/7 Wall St.
May-04-15 06:04PM  Enterprise Products Partners to Participate in Investor Meetings at noodls
06:04PM  Enterprise Prices $2.5 Billion of Senior Unsecured Notes at noodls
04:58PM  Enterprise Products Partners to Participate in Investor Meetings Business Wire
04:50PM  Enterprise Prices $2.5 Billion of Senior Unsecured Notes Business Wire
May-01-15 06:26PM  3 Key Takeaways From Enterprise Products' Earnings at Investopedia
Apr-30-15 07:30PM  Enterprise to Build New Crude Oil and Condensate Pipeline from Midland to Houston at noodls
06:32PM  Enterprise to Build New Crude Oil and Condensate Pipeline from Midland to Houston Business Wire
02:34PM  Enterprise Products Partners (EPD) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
10:11AM  Enterprise Products Miss on Earnings, Revenues in Q1 - Analyst Blog
10:00AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today
07:07AM  Q1 2015 Enterprise Products Partners LP Earnings Release - Before Market Open
06:42AM  Enterprise Reports Results for First Quarter 2015 at noodls
06:15AM  Enterprise Reports Results for First Quarter 2015 Business Wire
06:07AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Fin
06:00AM  Enterprise and Occidental Petroleum Form Company to Build Natural Gas Processing Facility in Delaware Basin Business Wire
Apr-29-15 09:03AM  Analyzing Energy Transfer Partners since the Last Earnings Release
Apr-28-15 07:33PM  Enterprise Products' Earnings: What to Watch at Investopedia
12:06PM  What Affected Kinder Morgans 1Q15 Earnings?
Apr-24-15 10:44AM  Inventory Gains at Cushing Slowed the Week Ending April 17
Apr-21-15 05:41PM  BP seeking bids for $2 bln in U.S. pipeline operations - Bloomberg
04:16PM  50% chance of lifting oil export ban this year: CEO at CNBC
08:59AM  A rare income-and-growth investment: energy pipelines at MarketWatch
08:45AM  Calls flow into Enterprise Products
Apr-15-15 03:57PM  How can retail and oil both go higher?
Apr-14-15 06:50PM  No Huddle Offense: Oil or retail?
05:07PM  Cushing Inventories Last Week Rise to Highest in 11 Years
10:05AM  Insight for Investors: Understanding MLP Contracts
Apr-13-15 04:06PM  Tax Consideration: How Are MLP Investors Taxed?
Apr-11-15 09:05PM  Magnetar Increases Its Position in TransCanada
12:05AM  Distributions Are Important for MLP Investors
Apr-10-15 02:00PM  Enterprise Products Increases Capacity on Pipeline System - Analyst Blog
Apr-09-15 07:10PM  Enterprise Offering Additional Capacity on Aegis Ethane Pipeline System at noodls
07:05PM  Enterprise Offering Additional Capacity on Aegis Ethane Pipeline System Business Wire
03:10PM  Enterprise Products Partners Raises Quarterly Distribution - Analyst Blog
Apr-08-15 04:50PM  Enterprise Declares Distribution; 43rd Consecutive Quarterly Distribution Increase at noodls
04:30PM  Enterprise Declares Distribution; 43rd Consecutive Quarterly Distribution Increase Business Wire
03:20PM  Enterprise Boosts Loading Capacity at Houston Ship Channel - Analyst Blog
Apr-06-15 04:20PM  Enterprise Products Increases Loading Capacity at Houston Ship Channel LPG Export Terminal at noodls
04:15PM  Enterprise Products Increases Loading Capacity at Houston Ship Channel LPG Export Terminal Business Wire
Mar-31-15 05:25PM  Where And How To Trade Energy Stocks at Investopedia
03:18PM  CFO Moves: Enterprise Products Partners, Insulet, Iconix Brand Group at The Wall Street Journal
02:10PM  Enterprise Products Partners CEO to Retire by 2015 End - Analyst Blog
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products in the United States and internationally. Its NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as import and export terminal services. This segment operates NGL pipelines aggregating approximately 19,400 miles; NGL and related product storage facilities; and 15 NGL fractionators. The company's Onshore Natural Gas Pipelines & Services segment operates approximately 19,300 miles of onshore natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. This segment also leases salt dome natural gas storage facilities; and markets natural gas. Its Onshore Crude Oil Pipelines & Services segment operates approximately 5,400 miles of onshore crude oil pipelines; and markets crude oil. This segment's pipelines gather and transport crude oil primarily in New Mexico, Oklahoma, and Texas to refineries, centralized storage terminals, and connecting pipelines. The company's Offshore Pipelines & Services segment operates approximately 2,350 miles of offshore natural gas and crude oil pipelines and 6 offshore hub platforms in the northern Gulf of Mexico offshore Texas, Louisiana, Mississippi, and Alabama. Its Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 680 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities, as well as refined products pipelines of 4,200 miles, as well as terminals and related marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SNELL RICHARD SDirectorJun 30Buy29.918,000239,28042,526Jun 30 04:23 PM
WILLIAMS RANDA DUNCANDirectorMar 13Buy31.013,225,057100,009,01833,708,091Mar 17 05:07 PM
WILLIAMS RANDA DUNCANDirectorMar 02Buy34.001,498,05550,933,8702,373,055Mar 04 05:44 PM
ORDEMANN WILLIAMGroup Senior Vice PresidentFeb 26Option Exercise16.14120,0001,936,200980,582Mar 02 04:22 PM
Bulawa Bryan F.SVP & TreasurerFeb 03Option Exercise16.1410,000161,350121,782Feb 05 04:49 PM
KNESEK MICHAEL JSVP, PAO, & ControllerFeb 03Option Exercise16.1460,000968,100617,912Feb 04 04:12 PM
CREEL MICHAEL AChief Executive OfficerFeb 03Option Exercise16.14180,0002,904,3001,722,264Feb 04 04:11 PM
FOWLER W RANDALLEVP & Chief Financial OfficerFeb 02Option Exercise16.14120,0001,936,200832,910Feb 04 04:10 PM
TEAGUE AJChief Operating OfficerFeb 02Option Exercise16.14120,0001,936,2001,448,268Feb 04 04:08 PM
AGN Allergan Inc. daily Stock Chart
AGN [NYSE]
Allergan Inc.
IndexS&P 500 P/E- EPS (ttm)-8.49 Insider Own0.30% Shs Outstand392.44M Perf Week0.03%
Market Cap120.36B Forward P/E14.29 EPS next Y21.46 Insider Trans- Shs Float391.05M Perf Month1.09%
Income-2262.20M PEG- EPS next Q4.40 Inst Own90.80% Short Float1.26% Perf Quarter2.97%
Sales14.64B P/S8.22 EPS this Y-40.80% Inst Trans0.00% Short Ratio2.17 Perf Half Y18.36%
Book/sh229.62 P/B1.34 EPS next Y20.21% ROA-3.20% Target Price348.90 Perf Year38.42%
Cash/sh5.43 P/C56.48 EPS next 5Y17.25% ROE-6.50% 52W Range201.91 - 317.72 Perf YTD19.15%
Dividend0.20 P/FCF61.69 EPS past 5Y-42.20% ROI-2.70% 52W High-3.47% Beta0.32
Dividend %0.07% Quick Ratio1.00 Sales past 5Y36.10% Gross Margin54.10% 52W Low51.90% ATR5.56
Employees21600 Current Ratio1.40 Sales Q/Q59.50% Oper. Margin-10.80% RSI (14)56.21 Volatility1.94% 1.68%
OptionableYes Debt/Eq0.67 EPS Q/Q-436.40% Profit Margin-14.80% Rel Volume0.68 Prev Close307.51
ShortableYes LT Debt/Eq0.64 EarningsAug 06 BMO Payout- Avg Volume2.26M Price306.70
Recom1.70 SMA201.15% SMA502.47% SMA20011.10% Volume1,540,729 Change-0.26%
Jul-06-15 05:45PM  Bulletproof stocks to protect your portfolio
07:44AM  Early movers: HUM, SRG, AAPL, POT, BABA & more at CNBC
07:00AM  Hedge funds like these stocks for the rest of the year
07:00AM  Allergan to Acquire Oculeve Dry Eye Disease Development Programs PR Newswire
Jul-02-15 09:46AM  Investors Wade Into 'Wide Moats' for Long-Term Gains
07:47AM  How much will you spend this July 4th?
Jul-01-15 01:13PM  Top Takeaways From BMO's Specialty Pharma Day
12:43PM  Allergan and Valeant: Who'll See the Bigger Benefit from Irritable Bowels? at Barrons.com
02:38AM  Willis-Towers Watson: A Merger of Equals---Not Exactly at The Wall Street Journal
12:39AM  Willis-Towers Watson: A Merger of EqualsNot Exactly at The Wall Street Journal
Jun-30-15 11:48AM  A New Rider in the Perrigo, Mylan, Teva Merger Merry-Go-Round at Barrons.com
Jun-29-15 04:05PM  Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast PR Newswire
10:48AM  Billionaires Cooperman and Larry Robbins Are Piling Into These Stocks at Insider Monkey
10:17AM  Billionaire Halvorsen and John Lykouretzos Are Betting On The Same Stocks at Insider Monkey
07:00AM  5 Rocket Stocks to Sidestep the Greek Drama at TheStreet
Jun-26-15 04:45PM  Eli Lilly Wins Alimta Patent Lawsuit in the UK, Shares Up - Analyst Blog
04:45PM  Zoetis Loses All Of Thursday's Spike On Valeant Buzz at Investor's Business Daily
03:38PM  Horizon Pharma Seen In Deal-Making Mode at Investor's Business Daily
01:46PM  20 Biotech and Healthcare Stocks The Richest Hedge Fund Billionaires Are Buying And Selling Now at Forbes
11:54AM  Valeant, Zoetis Shares in the Dog House on Takeout Speculation at Barrons.com
11:51AM  John Paulson riding health-care wave with new fund at CNBC
09:53AM  Cramer's Stop Trading: Intel & Horizon Pharma
09:22AM  Cramer's Mad Dash: Finish Line's victory lap
07:38AM  Valeant Pharmaceuticals And Zoetis: A True Mega Deal Is On The Horizon at Forbes
Jun-25-15 09:36AM  Third Point and Senator Investment Are Investing In The Same Stocks at Insider Monkey
08:37AM  Eli Lilly Wins Alimta Patent Case in U.K. at The Wall Street Journal
Jun-24-15 05:50PM  IBD Market Wrap - 06/24/15
10:14AM  How much the best-performing and worst-performing CEOs got paid at MarketWatch
09:39AM  Bill Ackman and Scott Ferguson Are Investing In The Same Stocks at Insider Monkey
Jun-23-15 06:39PM  Julian Robertson Adds 16 New Stakes to Portfolio
06:13PM  Cramer: Stocks killing it in a negative market at CNBC
03:57PM  FOMC and Greece Negotiation Breakdown Impact Financial Markets
Jun-22-15 06:00PM  Cramer: Top 7 plays on Greece
12:51PM  Jim Cramer: Netflix Can Go Higher but Don't Expect It to Double at TheStreet
09:40AM  Billionaire Mandels Investing Acumen Has Led Him To Williams Companies Inc and These Two Stocks at Insider Monkey
Jun-21-15 10:23AM  Allergan aims to keep beauty lead as needle replaces the knife at Financial Times
Jun-19-15 06:00AM  Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair at TheStreet
Jun-18-15 06:18PM  Cramer: Secret pattern to unlocking biotech riches at CNBC
04:45PM  KYTHERA Soars on $2.1 Billion Buyout Offer from Allergan - Analyst Blog
10:10AM  Company News for June 18, 2015 - Corporate Summary
10:09AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of KYTHERA Biopharmaceuticals, Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Allergan plc -- KYTH PR Newswire
06:00AM  Jim Cramer's Top Takeaways: Palo Alto Networks, Tesla, Ambarella, Allergan, Wingstop, Alkermes at TheStreet
01:14AM  Edited Transcript of AGN M&A conference call or presentation 17-Jun-15 12:30pm GMT
Apr-01-15 12:35PM  Valeant closes $11B deal for Raleigh's Salix Pharmaceuticals at bizjournals.com
Mar-24-15 02:35PM  Salix had a $13B offer on the table before accounting problems crashed share price at bizjournals.com
Mar-18-15 08:11AM  ALLERGAN INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure t
Mar-17-15 09:49PM  Sale of Allergan to Actavis is finalized; CEO David Pyott stepping down at Los Angeles Times
06:49PM  Actavis' Depression Drug Gains FDA Approval for New Dose - Analyst Blog
06:00PM  Cramer: Market cross currents
05:44PM  Valeant (VRX) Raises Salix Offer, Endo Withdraws Proposal - Analyst Blog
03:45PM  Allergan sale complete, CEO Pyott steps down at bizjournals.com
01:40PM  American Airlines Group (AAL) to Enter Coveted S&P 500 - Analyst Blog
01:39PM  Allergan sale to Actavis complete; CEO David Pyott is leaving at Los Angeles Times
Allergan, Inc. discovers, develops, and commercializes pharmaceuticals, biologics, medical devices, and over-the-counter products in the Unites States and internationally. It operates through two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including, ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, other prescription, and over-the-counter skin care products; and urology products. The Medical Devices segment provides a range of medical devices comprising breast implants for augmentation, revision, reconstructive surgery, and tissue expanders; and facial aesthetics products. The company also engages in the research and development of various products in ophthalmology, neuromodulators, migraine, urology, medical dermatology, and medical aesthetics. Allergan, Inc. markets and sells its products primarily through its subsidiaries, independent distributors, and regional sales and marketing organizations to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. The company primarily focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. It has collaboration agreements with Molecular Partners AG and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California. As of March 17, 2015, Allergan Inc. operates as a subsidiary of Actavis plc.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PYOTT DAVID E IChairman of the Board and CEOFeb 20Option Exercise0.001,3790166,379Feb 24 09:52 PM
Gangolli Julian SCVP & Pres, North AmericaFeb 20Option Exercise0.0051402,418Feb 24 09:44 PM
NSC Norfolk Southern Corporation daily Stock Chart
NSC [NYSE]
Norfolk Southern Corporation
IndexS&P 500 P/E13.96 EPS (ttm)6.23 Insider Own0.30% Shs Outstand304.85M Perf Week-2.17%
Market Cap26.50B Forward P/E13.30 EPS next Y6.54 Insider Trans-0.11% Shs Float303.75M Perf Month-5.46%
Income1.94B PEG1.53 EPS next Q1.48 Inst Own70.50% Short Float1.92% Perf Quarter-15.78%
Sales11.50B P/S2.30 EPS this Y5.60% Inst Trans0.04% Short Ratio2.65 Perf Half Y-18.98%
Book/sh39.63 P/B2.19 EPS next Y15.25% ROA5.90% Target Price101.41 Perf Year-13.91%
Cash/sh1.72 P/C50.58 EPS next 5Y9.13% ROE15.80% 52W Range86.74 - 115.65 Perf YTD-19.32%
Dividend2.36 P/FCF679.58 EPS past 5Y18.20% ROI11.40% 52W High-24.82% Beta1.20
Dividend %2.71% Quick Ratio0.90 Sales past 5Y7.80% Gross Margin38.90% 52W Low0.23% ATR1.34
Employees29482 Current Ratio1.00 Sales Q/Q-4.50% Oper. Margin30.60% RSI (14)29.38 Volatility1.35% 1.40%
OptionableYes Debt/Eq0.73 EPS Q/Q-15.30% Profit Margin16.80% Rel Volume0.67 Prev Close87.83
ShortableYes LT Debt/Eq0.69 EarningsJul 27 BMO Payout36.30% Avg Volume2.20M Price86.94
Recom2.60 SMA20-4.01% SMA50-8.63% SMA200-15.98% Volume1,466,356 Change-1.01%
Jun-08-15Reiterated Barclays Overweight $105 → $96
May-20-15Reiterated Argus Buy $125 → $115
Apr-14-15Reiterated Cowen Outperform $116 → $113
Apr-14-15Downgrade TD Securities Buy → Hold $120 → $110
Jan-27-15Upgrade Argus Hold → Buy $125
Jan-27-15Reiterated Cowen Outperform $115 → $116
Jan-27-15Reiterated Barclays Overweight $122 → $118
Jan-06-15Downgrade UBS Buy → Neutral $125 → $114
Oct-23-14Reiterated RBC Capital Mkts Sector Perform $127 → $123
Oct-14-14Initiated UBS Buy $130
Sep-22-14Reiterated Barclays Overweight $112 → $125
Jul-24-14Reiterated RBC Capital Mkts Sector Perform $111 → $114
Jun-30-14Upgrade Barclays Equal Weight → Overweight $110 → $112
Jun-24-14Reiterated FBR Capital Outperform $115 → $125
Jan-23-14Reiterated RBC Capital Mkts Sector Perform $91 → $100
Jan-23-14Reiterated Deutsche Bank Hold $91 → $96
Jan-23-14Reiterated Cowen Outperform $98 → $110
Jan-23-14Reiterated Barclays Equal Weight $93 → $101
Jan-16-14Downgrade Stifel Buy → Hold
Jan-13-14Reiterated FBR Capital Outperform $100 → $115
Jul-06-15 08:05PM  Why is CSX Getting Revalued by the Market?
Jul-01-15 04:23PM  Norfolk Southern to hold second-quarter 2015 earnings conference call July 27 PR Newswire
Jun-30-15 04:30PM  EXCLUSIVE: $34M Rickenbacker intermodal expansion planned at bizjournals.com
03:54PM  CSX Stock to Benefit from Strong 1Q15 Operating Performance
03:37PM  2nd half of the year: Rail stocks
09:31AM  'Rail-mageddon' Nears, Warns Credit Suisse
09:24AM  Cramer's Mad Dash: Rails challenged
Jun-25-15 08:42AM  Rough ride for railroad stocks
Jun-24-15 10:55PM  Can Key Support Cluster Get Railroad Stocks Back On Track?
03:38PM  Railroads some of biggest losers
Jun-22-15 12:15AM  Why Railroads Cant Keep Enough Boxcars in Service at The Wall Street Journal
Jun-21-15 05:33AM  Why Railroads Can't Keep Enough Boxcars in Service at The Wall Street Journal
Jun-11-15 06:00PM  Cramer: Free-fall in transports over
Jun-10-15 12:30PM  Norfolk Southern Hits 52-Week Low on Weak Q1, Shipments - Analyst Blog
Jun-08-15 06:00PM  Ambarella's a soon to be cult classic: Cramer
Jun-04-15 12:27PM  Norfolk Southern dedicates locomotive honoring nation's first responders PR Newswire
Jun-03-15 02:52PM  CSX Sees U.S. Coal Volumes Down At Least 5% at Investor's Business Daily
Jun-02-15 03:27PM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
Jun-01-15 03:41PM  Norfolk Southern brings "Train Your Brain" public safety campaign to Georgia PR Newswire
May-29-15 12:30PM  Halftime Portfolio: Accuray takeout?
12:04PM  June swoon or summer sizzler
May-28-15 10:28AM  Norfolk Southern Corporation -- Moody's assigns Baa1 rating to Norfolk Southern's new senior unsecured notes at Moody's
09:17AM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-26-15 12:22PM  Norfolk Southern EVP and CIO Butler to present at Deutsche Bank 2015 Global Industrials and Basic Materials Conference PR Newswire
May-22-15 04:06PM  The 52-Week Low Club for Friday at 24/7 Wall St.
10:37AM  Heller and Booth assume additional responsibilities at Norfolk Southern PR Newswire
May-21-15 03:43PM  Railroad Stocks in Trouble Over Lower Coal Shipments? - Analyst Blog
03:27PM  Transports running on fumes?
May-19-15 11:22AM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements a
May-18-15 02:16PM  Why Tesla is a short idea during the Fed liftoff at MarketWatch
May-15-15 04:33PM  Will Uncertain Energy Markets Spell Trouble for Railroads? - Analyst Blog
02:14PM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
May-14-15 01:10PM  Alan Shaw named Norfolk Southern executive vice president and chief marketing officer PR Newswire
11:28AM  Norfolk Southern CEO tells shareholders he's confident of long-term strengths and success PR Newswire
May-13-15 01:01PM  Seven dead after Amtrak derailment
May-12-15 08:00AM  Norfolk Southern recognizes rail customers for safe chemical handling PR Newswire
07:58AM  Will New Safety Rules Derail Rising Oil Train Accidents? at Fox Business
May-11-15 04:07PM  Will New Safety Rules Derail Increasing Oil Train Accidents? at Fox Business
May-07-15 12:27PM  Norfolk Southern President Squires to address Bernstein's 31st Annual Strategic Decisions Conference May 27 PR Newswire
May-06-15 03:00PM  Norfolk Southern CEO rails against oil train regulations at bizjournals.com
12:13PM  Oil Train Erupts in Flames in North Dakota at The Wall Street Journal
09:44AM  Norfolk Southern Executive Vice President Finance and CFO Marta Stewart to address Wolfe Research 8th Annual Global Transportation Conference on May 20 PR Newswire
May-05-15 02:55PM  Skylands Capitals top 5 holdings at MarketWatch
May-04-15 12:39PM  Ackman: Great management at Canadian Pacific
08:01AM  REPEAT-North American rail industry angered by new brake rule Reuters
May-01-15 08:11PM  10-Q for Norfolk Southern Corp. at Company Spotlight
05:41PM  North American rail industry angered by new brake rule Reuters
11:55AM  Latest 'fix' for California drought: Water by rail at CNBC
Apr-30-15 08:23AM  Norfolk Southern Corporation (SO) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
Apr-29-15 03:13PM  Norfolk Southern (NSC) Q1 Earnings In Line, Revenues Miss - Analyst Blog
10:05AM  Norfolk Southern (NSC) Q1 Earnings in Line, Revenues Miss - Tale of the Tape
09:30AM  Zacks Industry Outlook Highlights: Canadian National Railway, Union Pacific, CSX, Norfolk Southern and Canadian Pacific Railway - Press Releases
09:30AM  Zacks Industry Outlook Highlights: Canadian National Railway, Kansas City Southern, Norfolk Southern and CSX - Press Releases
08:50AM  Norfolk Southern meets 1Q profit forecasts
08:48AM  Norfolk Southern Profit Falls on Weak Coal Volume at The Wall Street Journal
08:45AM  Norfolk Southern Corp Earnings Call scheduled for 8:45 am ET today
08:36AM  Weak coal, strong dollar undermine Norfolk Southern profit
08:15AM  Norfolk Southern profit falls, undermined by weak coal volumes
08:03AM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:00AM  Norfolk Southern reports first-quarter 2015 results PR Newswire
07:07AM  Q1 2015 Norfolk Southern Corp Earnings Release - 08:00 am ET
Apr-28-15 06:35PM  Pennsylvania hires consultant to study oil trains at bizjournals.com
03:52PM  /C O R R E C T I O N -- Norfolk Southern Corporation/ PR Newswire
09:30AM  Zacks Industry Outlook Highlights: Union Pacific, CSX, Norfolk Southern and Kansas City Southern - Press Releases
Apr-27-15 01:40PM  Will Norfolk Southern's (NSC) Earnings Disappoint in Q1? - Analyst Blog
Apr-24-15 06:00PM  Making Money With Charles Payne: 04/24/15 at Fox Business
04:34PM  If You Want To Be Bullish, Check Out Transportation, Says Pro Tim Anderson
09:30AM  The Zacks Analyst Blog Highlights: Norfolk Southern, CSX, Covenant Transportation Group, Saia and Ryder System - Press Releases
09:06AM  Railroad play on track for long-term gains?
Apr-23-15 02:53PM  Union Pacific Misses Q1 Earnings, Sales on Soft Volumes - Analyst Blog
11:31AM  3 Transportation Stocks Trading at Great Values - Analyst Blog
Apr-21-15 05:44PM  CP Rail CEO says shareholder activism 'overdue' at U.S. rivals
05:09PM  Will Weak Coal Shipments Derail Union Pacific? at Investopedia
03:15PM  $1.5M rail extension planned for Triad industrial park at bizjournals.com
02:30PM  Maestri and Martinez assume new responsibilities for Norfolk Southern; Wimbush retires PR Newswire
11:08AM  Kansas City Southern Q1 Earnings, Revs Lag Estimates - Analyst Blog
09:30AM  The Zacks Analyst Blog Highlights: Norfolk Southern, Kansas City Southern, United Continental Holdings, Ryder System and Global Ship Lease - Press Releases
09:04AM  Kansas City Southern reports decline in 1st-qtr revenue
Apr-20-15 12:37PM  3 Likely Transportation Winners This Earnings Season - Earnings ESP
08:44AM  Five things you need to know today, and I have a guilty conscience this morning at bizjournals.com
07:26AM  Transportation Q1 Earnings Preview From Goldman Sachs
Apr-18-15 12:01AM  CSX Payouts Head North at Barrons.com
Apr-16-15 06:11AM  Class J 611 homecoming to kick off Norfolk Southern 21st Century Steam excursions PR Newswire
Apr-15-15 04:33PM  Forget Norfolk Southern, Go for These Transportation Stocks - Analyst Blog
02:35PM  Here's how CSX plans to improve in the second quarter at bizjournals.com
10:10AM  Stock Market News for April 15, 2015 - Market News
09:33AM  Norfolk Southern (NSC) Stock Price Target Lowered at Credit Suisse at TheStreet
09:29AM  Cramer: Transports could be leaders
09:20AM  CSX Corp. Q1 Earnings Meet, Revenues Miss Estimates - Analyst Blog
Apr-14-15 07:10PM  Lower fuel costs leads to higher profits for CSX and here's how shareholders will benefit at bizjournals.com
06:00PM  Cramer: Focus! Too much good to ignore
05:58PM  NYSE stocks posting largest percentage decreases AP
04:50PM  CSX Tops Q1 Earnings Views; OKs Payout Hike , Buyback at Investor's Business Daily
04:29PM  Alcatel-Lucent and JPMorgan are big market movers
04:19PM  CSX: Low fuel prices good for consumers
03:48PM  Earnings preview: Intel & CSX
03:22PM  Norfolk Southern's Bearish Q1 Outlook Hurts Railroad Stocks - Analyst Blog
02:58PM  This stock is sliding ahead of its earnings report at CNBC
02:35PM  Trading Nation: CSX dips ahead of earnings
01:33PM  Earnings alert sends Norfolk Southern offtrack at Financial Times
Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods. As of December 31, 2014, it operated approximately 20,000 miles of road in 22 states and the District of Columbia. The company also operates scheduled passenger trains; transports overseas freight through various Atlantic and Gulf Coast ports; and provides logistics services. In addition, it provides bimodal truckload transportation services primarily utilizing RoadRailer trailers, a hybrid technology that facilitates over-the-road and on-the-rail transportation in the eastern United States, as well as in Ontario and Quebec through a network of terminals. Further, the company engages in the acquisition, leasing, and management of coal, oil, gas, and minerals; development of commercial real estate; telecommunications; and leasing or sale of rail property and equipment. The company was founded in 1883 and is based Norfolk, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hurlbut Thomas EVice President and ControllerMar 06Sale108.191,000108,1909,726Mar 10 04:07 PM
Squires James APresidentJan 29Option Exercise0.004,000059,264Feb 02 06:25 PM
SEALE DONALD WExec. V.P. and CMOJan 29Option Exercise0.004,0000209,343Feb 02 06:23 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsJan 29Option Exercise0.004,0000144,495Feb 02 06:23 PM
Hurlbut Thomas EVice President and ControllerJan 29Option Exercise0.00700010,957Feb 02 06:23 PM
Manion Mark DExec. Vice President & COOJan 29Option Exercise0.004,000039,840Feb 02 06:23 PM
STEWART MARTA REVP-Finance and CFOJan 29Option Exercise0.001,250034,357Feb 02 06:23 PM
Butler Deborah HExec. V.P.- Planning & CIOJan 29Option Exercise0.004,000061,106Feb 02 06:21 PM
MOORMAN CHARLES WChairman & CEOJan 29Option Exercise0.0017,5000356,255Feb 02 06:21 PM
Earhart Cynthia CExec. VP - AdministrationJan 29Option Exercise0.001,25003,272Feb 02 06:21 PM
Earhart Cynthia CExec. VP - AdministrationDec 17Option Exercise49.432,02399,9872,023Dec 19 02:23 PM
STEWART MARTA REVP-Finance and CFODec 09Option Exercise49.562,01799,95232,134Dec 11 11:56 AM
SEALE DONALD WExec. V.P. and CMONov 24Option Exercise50.7432,0301,625,202231,302Nov 25 01:53 PM
SEALE DONALD WExec. V.P. and CMONov 24Sale116.1332,0303,719,644199,272Nov 25 01:53 PM
SEALE DONALD WExec. V.P. and CMONov 13Option Exercise42.764,676199,937199,533Nov 17 04:07 PM
Hurlbut Thomas EVice President and ControllerNov 10Sale116.131,150133,5509,310Nov 12 06:00 AM
STEWART MARTA REVP-Finance and CFONov 07Sale113.213,410386,05830,117Nov 12 06:00 AM
Squires James APresidentSep 04Option Exercise50.143,987199,910103,811Sep 08 04:46 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsSep 03Option Exercise50.7412,030610,402152,662Sep 04 03:28 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsSep 03Sale107.9512,0301,298,639140,632Sep 04 03:28 PM
MOORMAN CHARLES WChairman & CEOSep 02Option Exercise49.5677,4793,839,472394,390Sep 03 04:26 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsSep 02Option Exercise50.7410,000507,400150,632Sep 04 03:28 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsSep 02Sale107.6510,0001,076,548140,632Sep 04 03:28 PM
MOORMAN CHARLES WChairman & CEOSep 02Sale107.0077,4798,290,431316,911Sep 03 04:26 PM
MOORMAN CHARLES WChairman & CEOAug 29Option Exercise49.5645,5042,254,951362,415Sep 03 04:26 PM
MOORMAN CHARLES WChairman & CEOAug 29Sale107.0045,5044,868,928316,911Sep 03 04:26 PM
Squires James APresidentJul 29Option Exercise50.7432,0301,625,202131,854Jul 30 03:40 PM
Squires James APresidentJul 29Sale104.9532,0303,361,54999,824Jul 30 03:40 PM
Butler Deborah HExec. V.P.- Planning & CIOJul 25Option Exercise50.7434,0001,725,16083,995Jul 29 03:57 PM
Butler Deborah HExec. V.P.- Planning & CIOJul 25Sale107.3732,9603,538,83651,035Jul 29 03:57 PM
Hurlbut Thomas EVice President and ControllerJul 24Option Exercise50.127,477374,75317,909Jul 28 05:01 PM
Earhart Cynthia CExec. VP - AdministrationJul 24Option Exercise49.432,077102,6562,077Jul 28 03:07 PM
Hurlbut Thomas EVice President and ControllerJul 24Sale107.797,449802,95210,460Jul 28 05:01 PM
Earhart Cynthia CExec. VP - AdministrationJul 24Sale107.782,077223,8510Jul 28 03:07 PM
AET Aetna Inc. daily Stock Chart
AET [NYSE]
Aetna Inc.
IndexS&P 500 P/E19.41 EPS (ttm)6.05 Insider Own0.40% Shs Outstand349.20M Perf Week-9.70%
Market Cap41.01B Forward P/E14.35 EPS next Y8.19 Insider Trans-26.44% Shs Float347.82M Perf Month1.25%
Income2.15B PEG1.97 EPS next Q1.81 Inst Own90.20% Short Float1.33% Perf Quarter9.16%
Sales59.10B P/S0.69 EPS this Y6.60% Inst Trans0.02% Short Ratio1.83 Perf Half Y32.92%
Book/sh43.07 P/B2.73 EPS next Y10.46% ROA4.00% Target Price131.29 Perf Year41.94%
Cash/sh5.49 P/C21.40 EPS next 5Y9.84% ROE14.60% 52W Range71.44 - 134.40 Perf YTD32.87%
Dividend1.00 P/FCF14.97 EPS past 5Y14.90% ROI10.30% 52W High-12.63% Beta0.88
Dividend %0.85% Quick Ratio- Sales past 5Y10.80% Gross Margin- 52W Low64.37% ATR3.64
Employees48800 Current Ratio- Sales Q/Q7.90% Oper. Margin7.00% RSI (14)42.18 Volatility2.53% 2.50%
OptionableYes Debt/Eq0.54 EPS Q/Q20.90% Profit Margin3.60% Rel Volume6.51 Prev Close125.51
ShortableYes LT Debt/Eq0.52 EarningsAug 04 BMO Payout15.60% Avg Volume2.52M Price117.43
Recom2.00 SMA20-5.14% SMA500.66% SMA20020.03% Volume16,432,903 Change-6.44%
Jul-06-15Downgrade FBR Capital Outperform → Mkt Perform $130
Jun-26-15Reiterated Leerink Partners Outperform $145 → $150
Jun-24-15Initiated RBC Capital Mkts Sector Perform $159
Jun-17-15Reiterated Leerink Partners Outperform $135 → $145
May-12-15Reiterated Leerink Partners Outperform $130 → $135
Apr-29-15Reiterated Argus Buy $115 → $130
Mar-12-15Reiterated Argus Buy $103 → $115
Feb-04-15Reiterated UBS Buy $104 → $112
Feb-03-15Reiterated FBR Capital Outperform $99 → $105
Jan-20-15Reiterated Argus Buy $95 → $103
Dec-12-14Reiterated Stifel Buy $90 → $100
Dec-12-14Reiterated FBR Capital Outperform $93 → $99
Dec-12-14Reiterated Deutsche Bank Buy $88 → $94
Oct-03-14Upgrade Argus Hold → Buy $95
Jul-29-14Reiterated FBR Capital Outperform $80 → $93
Apr-25-14Reiterated Barclays Overweight $80 → $87
Mar-12-14Reiterated UBS Buy $82 → $86
Jan-08-14Reiterated Barclays Overweight $75 → $80
Dec-13-13Reiterated FBR Capital Outperform $71 → $75
Nov-25-13Reiterated UBS Buy $76 → $82
Jul-07-15 12:06AM  Deal-Related Jitters Hit Humana, Aetna at The Wall Street Journal
Jul-06-15 07:18PM  Aetna-Humana Merger: Why Investors Are Uncertain and Wary - Stocks in the News -6.44%
07:13PM  Deal-Related Jitters Hit Humana, Aetna at The Wall Street Journal
06:32PM  Aetna CEO addresses antitrust concerns over Humana deal Reuters
06:26PM  Aetna-Humana Deal May Never Be Consummated at Barrons.com
06:21PM  Aetna Plunges After $37 Billion Humana Acquisition at TheStreet
06:20PM  Humana cuts outlook, raising new concerns about Aetna deal Reuters
05:43PM  HUMANA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Humana Inc. PR Newswire
05:14PM  Aetna Plunges to Trail S&P 500 Following $37B Humana Acquisition at TheStreet
04:59PM  M&A activity drives price swings at Financial Times
04:45PM  US stocks slip amid global sell-off after Greek 'no' vote
04:40PM  Trending Now: Aetna
04:30PM  Jack Levy's Swan Song: Selling Humana at The Wall Street Journal
04:19PM  Late Rally Comes Up Short; Heritage Insurance Hits New High at Investor's Business Daily
04:09PM  US stocks end lower after Greek 'no' vote; Europe sinks
03:28PM  Aetna strikes first, acquiring Humana in largest insurance deal in history
02:44PM  Social Media Beat: China, Greece, Crude Oil And The Aetna-Humana Deal
02:37PM  Robbins Arroyo LLP: Acquisition of Humana Inc. (HUM) by Aetna Inc. (AET) May Not Be in Shareholders' Best Interests PR Newswire
02:31PM  How The Street Is Reacting To The Aetna-Humana Deal
01:55PM  How the Aetna-Humana Deal Could Open Floodgates for Insurance Mergers at TheStreet
01:31PM  Health care insurer stocks mixed after Aetna, Humana deal
01:16PM  Monday ETF Winners: Health Care ETF Inches Up On Deals at Investor's Business Daily
01:10PM  Megamergers could reshape health insurance marketplace (Video) at bizjournals.com
12:39PM  Investors Wary of Aetna-Humana Deal at The Wall Street Journal
12:27PM  4 Stocks, 4 trades: GPRO, TRIP, WTW & AET
12:09PM  Aetna, Humana CEOs Say Industry Consolidation Good for Consumer at Fox Business
11:25AM  Aetna & Humana rush to deal; Guess lifted; Weight Watchers gain
11:23AM  Worries Surface About Aetna's Credit After Humana Purchase at Barrons.com
11:07AM  Low rates weigh on insurers even as it feeds their merger mania at Financial Times
10:45AM  Health Insurance Mergers Falling Into Place at 24/7 Wall St.
10:31AM  With Merger Deal, Aetna, Humana Get Ahead of the Pack at The Wall Street Journal
10:30AM  The $37B merger that can affect your health at CNBC
10:29AM  Aetna: Not Much to Get Excited About in Humana Acquisition at Barrons.com
10:23AM  HUMANA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
10:20AM  Aetna (AET) Stock Declines on Analyst Downgrade at TheStreet
10:13AM  Aetna, Humana CEOs talk antitrust concerns
10:01AM  US STOCKS-Wall St falls as Greece concerns weigh
09:54AM  Aetna-Humana Deal Could Create PBM, Ending CVS Relationship at Forbes
09:44AM  Aetna CEO says built expectations for asset sales into deal
09:41AM  US stocks open lower after Greek 'no' vote on bailout
09:34AM  Humana Cuts Outlook After Aetna Announces Buyout at Investor's Business Daily
09:33AM  Faber Report: Aetna-Humana merger
09:10AM  Weight Watchers buyer? Nike's World Cup move; Humana warning
09:08AM  US STOCKS-Wall St set to open lower as Greece concerns weigh
09:02AM  Aetna's Humana Deal Pressures Cigna to Agree on Anthem Offer
08:51AM  Health care's urge to merge
08:26AM  Deals of the Day: Latest on the Health-Insurer Front, Samsung Setback at The Wall Street Journal
08:08AM  Humana provides downbeat profit outlook ahead of discussion of Aetna buyout at MarketWatch
08:05AM  Humana, Aetna hope deal will give them edge in antitrust review at bizjournals.com
08:01AM  Analysts' Actions -- Aetna, GoPro, Union Pacific and More
07:48AM  AETNA INC /PA/ Files SEC form 8-K, Other Events
07:40AM  Morning Movers: Weight Watchers Jumps on Takeover Talk; Aetna Tumbles on Humana Acquisition at Barrons.com
07:27AM  5 Best-Performing S&P 500 Stocks Of 2015
06:30AM  Aetna-Humana deal puts WellCare in the spotlight at bizjournals.com
06:29AM  10 things you need to know before the opening bell
06:00AM  Insurance mergers getting hot
12:19AM  Aetna and Humana: Justifying the Prize at The Wall Street Journal
12:18AM  With Merger Deal, Aetna, Humana Get Ahead of the Pack at The Wall Street Journal
12:18AM  How the Affordable Care Act Is Reducing Competition at The Wall Street Journal
12:01AM  Aetnas Humana Deal Pressures Cigna to Agree on Anthem Takeover at Bloomberg
Jul-05-15 08:03PM  Aetna, Humana Hurry to the Altar at The Wall Street Journal
06:44PM  How the Affordable Care Act Is Reducing Competition at The Wall Street Journal
05:56PM  Asia Corporate Watch at The Wall Street Journal
Jul-04-15 11:28AM  Insurers choose partners, and dance floor shrinks at CNBC
Jul-03-15 10:20PM  Rivals Lurked Behind Aetna's Deal With Humana at The Wall Street Journal
07:30PM  Aetna to buy Humana as health insurer landscape shifts
06:27PM  Aetna to buy Humana for $37bn in cash and shares at Financial Times
04:56PM  Humana & Aetna: Finally at Barrons.com
04:13PM  Aetna's Humana deal to bring scrutiny on other insurer tie-ups -experts Reuters
03:56PM  Aetna, Humana CEOs say deal bolsters Medicare, Medicaid businesses at USA TODAY
02:56PM  Aetna-Humana Merger Marks Sway of Health-Care Law at The Wall Street Journal
02:40PM  Health Net (HNT) to Be Acquired by Centene for $6.8 Billion - Analyst Blog
02:34PM  Hedge Funds Were Right About Humana Inc (HUM) at Insider Monkey
01:15PM  Insurer merger mania paints muddied picture for consumers
12:36PM  Aetna to Buy Humana for $37 Billion in Cash and Stock at TheStreet
12:28PM  Aetna to buy Humana for $37 bln in largest insurance deal Reuters
11:16AM  Aetna buys Humana for $37B amid record number of health care deals at USA TODAY
10:57AM  Aetna's $37B Humana Deal Expands Role In Medicare's Value-Based Care Push at Forbes
10:16AM  Aetna Buys Humana For $37 Billion, But Deal Doesn't Add Up at Forbes
09:50AM  Humana (HUM) to be Acquired by Aetna for $37B by 2H16 - Analyst Blog
09:46AM  Humana CEO told employees of sale via email at 2:38 a.m. at bizjournals.com
09:05AM  Insurer Aetna to buy Humana in $35B deal
08:30AM  Obamacare Prices Could Rise If Blue Cross Plans Face More Competition at Forbes
07:58AM  Let's make a deal: mega-mergers drive M&A frenzy
07:26AM  Insurer Aetna to buy Humana in $37B deal
06:42AM  Aetna is buying Humana for $37 billion
05:59AM  Insurer Aetna agrees to buy competitor Humana in deal valued at $37B
05:56AM  Aetna to buy Humana for $37 billion at Fortune
05:38AM  Aetna-Humana Adds to Takeover Frenzy Among U.S. Health Insurers at Bloomberg
05:38AM  Aetna-Humana Adds to Takeover Frenzy Among U.S. Health Insurers
03:03AM  Humana agrees to be acquired by Aetna at bizjournals.com
03:03AM  Aetna to Acquire Humana for $37B, $230/Sh Cash, Stock Deal at Barrons.com
02:33AM  Aetna to buy Humana for $37 bln in cash and stock Reuters
02:09AM  Aetna to acquire Humana for $37 billion at CNBC
02:08AM  Aetna to Acquire Humana for $37 Billion, Combined Entity to Drive Consumer-Focused, High-Value Health Care Business Wire
01:30AM  UPDATE 4-Aetna nears deal to buy Humana for about $34 bln -sources
01:08AM  PRESS DIGEST- New York Times business news - July 3 Reuters
Jul-02-15 11:17PM  Anthem, Cigna Talking as Centene Makes Deal at The Wall Street Journal
10:29PM  Reports: Aetna close to $34 billion Humana deal at USA TODAY
09:53PM  Aetna Nears $34 Billion Cash and Stock Humana Acquisition
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management services, dental, behavioral health, and vision plans on an insured basis, and an employer-funded or administrative basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, and other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. This segment offers its products and services to multi-site national, mid-sized, and small employers. The Group Insurance segment provides life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which offer the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. This segment provides its products to employers that sponsor its products for the benefit of their employees and their employees' dependents. The Large Case Pensions segment manages retirement products, including pension and annuity products primarily for tax-qualified pension plans. It offers its products to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Parmeswar RajanVP/Controller/Chief Acct OffJun 01Sale119.2462374,2863,000Jun 03 04:33 PM
Zubretsky Joseph MSenior EVP, HealthagenMar 31Sale107.43100,00010,742,506217,087Apr 01 04:28 PM
Zubretsky Joseph MSenior EVP, HealthagenMar 30Sale108.49100,00010,848,673317,087Apr 01 04:28 PM
Zubretsky Joseph MSenior EVP, HealthagenMar 27Sale107.2486,9589,325,298417,087Mar 30 04:41 PM
Zubretsky Joseph MSenior EVP, HealthagenMar 26Option Exercise50.70138,0687,000,048605,155Mar 30 04:41 PM
Zubretsky Joseph MSenior Executive Vice PresMar 26Sale106.2387,1239,255,034467,087Mar 26 05:03 PM
McCarthy Margaret MEVP, Operations & TechnologyMar 26Sale106.0427,6702,934,23781,888Mar 30 04:41 PM
Zubretsky Joseph MSenior Executive Vice PresMar 25Option Exercise44.22288,62612,763,042830,656Mar 26 05:03 PM
HACKMAN FRANKLIN BARBARADirectorMar 25Sale108.753,000326,23823,007Mar 26 04:59 PM
Zubretsky Joseph MSenior Executive Vice PresMar 25Sale107.8574,9438,082,779554,210Mar 26 05:03 PM
Zubretsky Joseph MSenior Executive Vice PresMar 24Option Exercise32.11207,1016,650,013674,188Mar 26 05:03 PM
Casazza William JamesExec. VP & General CounselMar 17Sale105.0714,0001,470,92742,286Mar 19 04:25 PM
Coye Molly JoelDirectorMar 02Sale100.272,500250,6757,215Mar 03 04:25 PM
Parmeswar RajanVP/Controller/Chief Acct OffFeb 10Sale95.605,300506,6673,623Feb 12 04:43 PM
SRE Sempra Energy daily Stock Chart
SRE [NYSE]
Sempra Energy
IndexS&P 500 P/E18.57 EPS (ttm)5.38 Insider Own0.10% Shs Outstand247.58M Perf Week0.47%
Market Cap24.74B Forward P/E19.23 EPS next Y5.20 Insider Trans-32.65% Shs Float234.38M Perf Month-3.54%
Income1.35B PEG2.34 EPS next Q0.99 Inst Own73.10% Short Float1.15% Perf Quarter-8.93%
Sales10.90B P/S2.27 EPS this Y15.50% Inst Trans0.00% Short Ratio2.59 Perf Half Y-9.67%
Book/sh46.44 P/B2.15 EPS next Y6.83% ROA3.50% Target Price121.54 Perf Year1.77%
Cash/sh1.52 P/C65.61 EPS next 5Y7.93% ROE11.90% 52W Range93.68 - 114.77 Perf YTD-9.08%
Dividend2.80 P/FCF- EPS past 5Y0.50% ROI5.90% 52W High-12.94% Beta0.37
Dividend %2.80% Quick Ratio0.90 Sales past 5Y6.30% Gross Margin98.50% 52W Low6.64% ATR1.45
Employees17046 Current Ratio1.00 Sales Q/Q-4.30% Oper. Margin18.40% RSI (14)40.27 Volatility1.30% 1.37%
OptionableYes Debt/Eq1.24 EPS Q/Q75.80% Profit Margin12.40% Rel Volume1.11 Prev Close100.38
ShortableYes LT Debt/Eq1.13 EarningsAug 06 BMO Payout49.00% Avg Volume1.04M Price99.91
Recom2.00 SMA20-1.67% SMA50-4.10% SMA200-6.32% Volume1,154,451 Change-0.47%
May-06-15Reiterated Barclays Overweight $117 → $120
Sep-22-14Reiterated RBC Capital Mkts Outperform $106 → $115
Aug-14-14Reiterated UBS Buy $106 → $111
Apr-14-14Initiated UBS Buy $106
Apr-02-14Reiterated RBC Capital Mkts Outperform $102 → $104
Jan-06-14Reiterated Barclays Overweight $101 → $97
May-28-13Upgrade Barclays Equal Weight → Overweight $85 → $90
Apr-24-13Reiterated Barclays Equal Weight $77 → $85
Apr-23-13Downgrade ISI Group Buy → Neutral
Feb-27-13Reiterated Barclays Equal Weight $70 → $77
Jan-07-13Upgrade ISI Group Neutral → Buy
Jul-23-12Downgrade Argus Buy → Hold
Apr-03-12Reiterated Barclays Equal Weight $60 → $63
Nov-07-11Reiterated RBC Capital Mkts Sector Perform $54 → $57
Jun-24-11Initiated RBC Capital Mkts Sector Perform $55
Apr-08-11Reiterated Barclays Capital Equal Weight $54 → $57
Feb-28-11Downgrade Barclays Capital Overweight → Equal Weight $57 → $55
Dec-10-10Initiated Oppenheimer Perform $56
Aug-04-10Reiterated Barclays Capital Overweight $56 → $59
Mar-08-10Upgrade Barclays Capital Equal Weight → Overweight $56 → $57
Jun-30-15 04:00PM  Mexico Moving Forward With Major Natural Gas Pipeline
Jun-23-15 01:30PM  SDG&E Has Sufficient Power Supplies To Meet Summer Demand PR Newswire
Jun-19-15 07:04PM  Here's Why Sempra Is Moving Ahead With Its MLP at Investopedia
Jun-17-15 06:40PM  SDG&E Honors The City Of San Diego And Balboa Park As Energy Efficiency Grand Champions PR Newswire
02:50PM  Sempra Energy to Form MLP with LNG, Green Energy Assets - Analyst Blog
Jun-16-15 05:47PM  Sempra Energy Moves Forward With Plans for Gas Partnership at Bloomberg
04:55PM  Sempra Energy to create MLP to hold LNG, renewable energy assets Reuters
04:05PM  Sempra Energy to Pursue Formation of Sempra Partners, LP PR Newswire
11:51AM  Sempra Energy Declares Common Dividend PR Newswire
Jun-10-15 08:00AM  SoCalGas' Energy Resource Center Celebrates 20th Anniversary; First to Receive LEED "green building" recognition in California PR Newswire
Jun-09-15 09:30AM  Zacks Industry Outlook Highlights: Chesapeake Utilities, DTE Energy, Sempra Energy and WGL Holdings - Press Releases
Jun-08-15 03:32PM  Utility Industry Stock Outlook - June 2015 - Zacks Analyst Interviews
03:32PM  Utility Industry Stock Outlook - June 2015 - Industry Outlook
Jun-03-15 08:29PM  Diverse Coalition Signs Agreement Supporting SDG&E'S Electric Vehicle Charging Program PR Newswire
07:24AM  Sempra LNG And Woodside Sign Memorandum Of Understanding For Potential Development Of Natural Gas Liquefaction Facility At Port Arthur, Texas PR Newswire
Jun-02-15 09:16PM  More SoCalGas Low-Income Customers Eligible for Bill-Assistance Programs PR Newswire
Jun-01-15 06:47PM  5 Things Sempra Energy Wants Investors to Know at Investopedia
01:25PM  Microgrid Powers Borrego Springs To Avoid Major Outage PR Newswire
May-28-15 02:00PM  Sempra Energy's Renewable Expansion to Drive Growth - Analyst Blog
12:20PM  Will Growth at Questar be Marred by Weak Commodity Prices? - Analyst Blog
May-26-15 04:31PM  SoCalGas Declares Preferred Dividends PR Newswire
May-21-15 11:00AM  Sempra U.S. Gas & Power Solar Plant First in U.S. to Receive Prestigious Safety Recognition PR Newswire
May-20-15 05:18PM  SEMPRA ENERGY Files SEC form 8-K, Change in Directors or Principal Officers
May-15-15 05:25PM  SEMPRA ENERGY Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-14-15 01:19PM  SoCalGas Pursues Expanded Pipe Replacement, Repair Program; Utility to Accelerate Repair of Non-Hazardous Leaks, Reduce Emissions PR Newswire
May-13-15 04:20PM  3 Takeaways From Sempra Energy's Earnings at Investopedia
May-12-15 11:00AM  SoCalGas Hosts Free Natural Gas Trucking Workshops PR Newswire
May-06-15 02:09PM  Moody's Affirms 11 Classes of WBCMT 2006-C28 at Moody's
May-05-15 07:44PM  Sempra Energy (SRE) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
02:46PM  Sempra Energy Beats Q1 Earnings Estimates, Reaffirms View - Analyst Blog
01:00PM  Sempra Energy Earnings Call scheduled for 1:00 pm ET today
12:06PM  SEMPRA ENERGY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
10:52AM  Sempra Energy's First-Quarter 2015 Earnings Rise at noodls
10:13AM  Sempra Energy (SRE) Beats on Q1 Earnings - Tale of the Tape
09:47AM  Sempra Energy's Profit Rises 77% at The Wall Street Journal
09:30AM  The Zacks Analyst Blog Highlights: Exelon, NextEra Energy, Wisconsin Energy, Sempra Energy and Southwest Gas - Press Releases
09:09AM  Sempra beats 1Q profit forecasts
09:00AM  Sempra Energy's First-Quarter 2015 Earnings Rise PR Newswire
07:07AM  Q1 2015 Sempra Energy Earnings Release - 09:00 am ET
May-04-15 02:00PM  SDG&E Presents $1.2 Million Incentive Check To Pala Band Of Mission Indians PR Newswire
01:35PM  3 Utilities to Bet on as Rate Hike Still Remains Uncertain - Earnings ESP
May-01-15 05:06PM  Will Sempra Energy (SRE) Beat Earnings Estimates Again? - Analyst Blog
Apr-30-15 04:47PM  Sempra U.S. Gas & Power, Consolidated Edison Development Dedicate Nevada Solar Plant at noodls
04:21PM  Ienova Rallies Among Latin IPOs in Infrastructure Boom at Bloomberg
04:01PM  Sempra U.S. Gas & Power, Consolidated Edison Development Dedicate Nevada Solar Plant PR Newswire
09:00AM  U.S. Department Of Energy, SDG&E Partner To Improve Resiliency Of Nation's Electric Grid PR Newswire
Apr-29-15 02:50PM  Vestas Wins 78-Megawatt Order From Sempra for Minnesota Project at Bloomberg
Apr-24-15 02:19PM  SDG&E Offers Tips For Safe Planting This Arbor Day at noodls
02:15PM  SDG&E Offers Tips For Safe Planting This Arbor Day PR Newswire
Apr-23-15 07:24PM  April is National Safe Digging Month: Natural Gas Safety is a Shared Responsibility, Says SoCalGas PR Newswire
06:30PM  Local Contractors And SDG&E Customers Reminded To "Call 8-1-1 Before You Dig" PR Newswire
05:19PM  Sempra Acquires 78-Megawatt Minnesota Wind Farm From Geronimo at Bloomberg
11:38AM  Analyzing Cheniere Energy Partners Historical Performance
11:03AM  Sempra U.S. Gas & Power Announces Acquisition of Minnesota Wind Project at noodls
11:00AM  Sempra U.S. Gas & Power Announces Acquisition of Minnesota Wind Project PR Newswire
01:52AM  Japan's Toho Gas to buy Cameron LNG from M'bishi Corp
Apr-21-15 09:24AM  Sempra Energy To Report First-Quarter 2015 Earnings May 5 at noodls
09:00AM  Sempra Energy To Report First-Quarter 2015 Earnings May 5 PR Newswire
Apr-20-15 01:14PM  SoCalGas honored by EPA as 2015 ENERGY STAR® Partner of the Year PR Newswire
Apr-14-15 01:00PM  U.S. to become a net exporter of natgas by 2017 -EIA Reuters
08:10AM  Mars May Hold Liquid Water, NASA Curiosity Rover Finds at MarketWatch
Apr-13-15 05:15PM  SoCalGas launches power-to-gas project tests at bizjournals.com
03:30AM  SoCalGas Launches First Power-to-Gas Project in U.S. at noodls
Apr-08-15 06:00PM  Sempra Energy CEO Debra Reed Nominated to Caterpillar Board of Directors at noodls
04:00PM  SoCalGas Hosts 14th Annual Municipal Green Building Conference PR Newswire
Apr-07-15 07:05PM  SoCalGas Sponsors Seven Nonprofit Groups for Earth Month Events PR Newswire
Apr-06-15 01:33PM  Six trades to go before the closing bell at CNBC
01:28PM  SDG&E Encourages Customers To Keep Mylar Balloons Away From Power Lines PR Newswire
Mar-31-15 07:05PM  8point3 Energy: First Solar and SunPower Joint Yieldco
06:41PM  /C O R R E C T I O N -- Southern California Gas Co./ PR Newswire
04:44PM  Study Finds Methane Emissions from U.S. Natural Gas Distribution Systems 36 to 70 Percent Lower Than Current EPA Estimates at noodls
Mar-30-15 04:20PM  FAA Authorizes SDG&E To Fly Unmanned Aircraft Systems Throughout Service Territory PR Newswire
03:05PM  TerraForm Power: Where the Wind Meets the Sun
Mar-24-15 06:59PM  SoCalGas Joins 2-1-1 Orange County to Launch Internet Site to Help Veterans and their Families Gain Greater Access to Services at noodls
06:59PM  Sempra Energy Submits Port Arthur Liquefaction-Export Facilities For Pre-File Review With FERC at noodls
06:54PM  SoCalGas Joins 2-1-1 Orange County to Launch Internet Site to Help Veterans and their Families Gain Greater Access to Services PR Newswire
Mar-23-15 08:32AM  Sempra Energy Submits Port Arthur Liquefaction-Export Facilities For Pre-File Review With FERC PR Newswire
Mar-18-15 05:14PM  Sempra Energy's $28 Billion Opportunity in Mexico at Investopedia
Mar-17-15 08:58PM  Chubut, Province of -- Moody's assigns Caa1/Baa1.ar debt ratings to the Province of Chubut's Class 2 Notes at Moody's
01:30PM  SDG&E To Award $1 Million In Grants To Local Environmental Non-Profits PR Newswire
Mar-16-15 07:46PM  SDG&E Continues Focus On Rate Reform at noodls
07:31PM  SDG&E Continues Focus On Rate Reform PR Newswire
Mar-13-15 01:17PM  SDG&E Warns Customers About SDG&E Imposter at noodls
12:10PM  SDG&E Warns Customers About SDG&E Imposter PR Newswire
09:45AM  SEMPRA ENERGY Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-12-15 09:12AM  Sempra Energy To Webcast Analyst Conference March 26 at noodls
09:00AM  Sempra Energy To Webcast Analyst Conference March 26 PR Newswire
Mar-07-15 01:04PM  SEMPRA ENERGY Financials
Mar-06-15 04:19PM  SEMPRA ENERGY Files SEC form 8-K, Other Events
Mar-03-15 08:06PM  SoCalGas Reports Record Spending with Diverse Suppliers PR Newswire
01:02PM  Sempra Energy Reports Higher 2014 Earnings at noodls
12:35PM  SDG&E Exceeds Diverse Spending Goals Nine Years In A Row PR Newswire
Mar-02-15 10:35PM  What Is Sempra Energys Future With LNG? at Investopedia
Feb-27-15 02:23PM  SDG&E Unveils New Water-Wise Landscaping Project At Kearny Mesa Headquarters PR Newswire
10:49AM  Sempra Energy (SRE) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
Feb-26-15 02:02PM  Sempra Energy Tops Q4 Earnings Estimates, Guides for 2015 - Analyst Blog Zacks
01:00PM  Sempra Energy Earnings Call scheduled for 1:00 pm ET today CCBN
11:51AM  SEMPRA ENERGY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
10:15AM  Sempra Energy (SRE) Beats on Q4 Earnings, Misses on Revenues - Tale of the Tape Zacks
09:35AM  Sempra Energy Earnings Rise on Latin America Growth at The Wall Street Journal
Sempra Energy operates as an energy services holding company worldwide. The company's San Diego Gas & Electric Company segment transmits and distributes electricity and/or natural gas. As of February 23, 2015, this segment provided energy service approximately to 3.4 million consumers through 1.4 million electric meters and 878,000 natural gas meters in San Diego and southern Orange counties. Its Southern California Gas Company segment transmits, distributes, and stores natural gas. As of February 6, 2015, this segment served approximately to 21 million consumers through 5.8 million meters in 500 communities. This segment's service territory comprises approximately 20,000 square miles throughout central and Southern California. The company's Sempra South American Utilities segment provides electricity distribution services through 9,941 miles of distribution lines, 342 miles of transmission lines, and 47 substations. Its Sempra Mexico segment owns and operates a natural gas-fired power plant and a wind generation facility in Baja California, Mexico; natural gas distribution systems; natural gas pipelines and propane systems; and liquefied natural gas regasification terminals. The company's Sempra Renewables segment develops solar electric generation facilities in Nevada, Arizona, and California, as well as develops wind electric generation facilities in Mexico. Its Sempra Natural Gas segment owns and operates a natural gas distribution utility located in Mobile and Baldwin counties in Alabama; and a natural gas distribution utility in Forrest County, Mississippi. The company primarily serves residential, commercial, and industrial customers. Sempra Energy was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REED DEBRA LChairman and CEOJul 01Sale98.5035,7293,519,30757,764Jul 01 06:58 PM
SNELL MARK APresidentMay 11Option Exercise55.9021,5001,201,850117,312May 11 01:19 PM
SNELL MARK APresidentMay 11Sale106.1021,5002,281,15095,812May 11 01:19 PM
SNELL MARK APresidentMay 08Option Exercise55.905,600313,040101,412May 11 01:19 PM
SNELL MARK APresidentMay 08Sale106.015,600593,65695,812May 11 01:19 PM
BROCKSMITH JAMES G JRDirectorMar 05Option Exercise64.815,000324,0508,696Mar 06 12:19 PM
BROCKSMITH JAMES G JRDirectorMar 05Sale108.735,000543,6503,696Mar 06 12:19 PM
OUCHI WILLIAM GDirectorMar 04Option Exercise64.815,000324,05020,623Mar 05 08:09 PM
OUCHI WILLIAM GDirectorMar 04Sale107.855,000539,25015,623Mar 05 08:09 PM
REED DEBRA LChairman and CEOJan 21Sale114.0417,4821,993,65357,764Jan 22 03:35 PM
ROWLAND G JOYCESenior VPJan 20Sale113.2113815,623119Jan 20 05:37 PM
REED DEBRA LChairman and CEOJan 14Sale110.5117,0771,887,15074,840Jan 15 12:15 PM
ROWLAND G JOYCESenior VPJan 06Sale109.4912,4841,366,829118Jan 07 12:06 PM
ROWLAND G JOYCESenior VPOct 13Option Exercise61.415,350328,5445,467Oct 14 02:42 PM
ROWLAND G JOYCESenior VPOct 13Sale105.345,350563,569117Oct 14 02:42 PM
ROWLAND G JOYCESenior VPSep 05Option Exercise61.414,250260,9934,367Sep 05 06:40 PM
ROWLAND G JOYCESenior VPSep 05Sale107.024,250454,835117Sep 05 06:40 PM
ROWLAND G JOYCESenior VPAug 11Option Exercise55.903,720207,9483,837Aug 11 03:07 PM
ROWLAND G JOYCESenior VPAug 11Sale101.483,720377,506117Aug 11 03:07 PM
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E26.13 EPS (ttm)5.46 Insider Own0.30% Shs Outstand209.39M Perf Week0.43%
Market Cap29.87B Forward P/E16.85 EPS next Y8.47 Insider Trans-12.01% Shs Float208.78M Perf Month2.19%
Income1.08B PEG2.30 EPS next Q2.00 Inst Own84.70% Short Float2.14% Perf Quarter1.27%
Sales8.46B P/S3.53 EPS this Y28.50% Inst Trans0.05% Short Ratio4.29 Perf Half Y2.85%
Book/sh36.51 P/B3.91 EPS next Y19.65% ROA6.00% Target Price159.91 Perf Year20.83%
Cash/sh9.32 P/C15.30 EPS next 5Y11.34% ROE19.00% 52W Range110.74 - 148.74 Perf YTD3.36%
Dividend2.40 P/FCF80.08 EPS past 5Y4.80% ROI14.10% 52W High-4.09% Beta0.93
Dividend %1.68% Quick Ratio1.00 Sales past 5Y3.90% Gross Margin50.90% 52W Low28.81% ATR1.67
Employees30619 Current Ratio1.60 Sales Q/Q-1.00% Oper. Margin19.20% RSI (14)57.17 Volatility1.27% 1.08%
OptionableYes Debt/Eq1.93 EPS Q/Q-25.50% Profit Margin12.80% Rel Volume1.35 Prev Close143.18
ShortableYes LT Debt/Eq1.69 EarningsAug 06 BMO Payout41.00% Avg Volume1.04M Price142.65
Recom2.00 SMA201.17% SMA501.18% SMA2004.56% Volume1,410,597 Change-0.37%
Jul-02-15Resumed Barclays Equal Weight $158
Jun-29-15Upgrade UBS Neutral → Buy $159 → $167
Mar-24-15Reiterated Canaccord Genuity Hold $125 → $149
Mar-10-15Initiated UBS Neutral $159
Feb-11-15Reiterated Argus Buy $140 → $156
Feb-06-15Reiterated RBC Capital Mkts Outperform $145 → $150
Oct-08-14Reiterated RBC Capital Mkts Sector Perform $116 → $132
Oct-07-14Upgrade Stifel Hold → Buy $153
Oct-07-14Reiterated Canaccord Genuity Hold $113 → $125
Oct-07-14Reiterated Argus Buy $125 → $140
Aug-01-14Reiterated Barclays Underweight $115 → $121
May-09-14Reiterated RBC Capital Mkts Sector Perform $109 → $113
Apr-07-14Reiterated ISI Group Buy $123 → $130
Jan-09-14Reiterated Barclays Underweight $106 → $112
Nov-05-13Reiterated Cowen Buy $111 → $117
Aug-02-13Reiterated Barclays Underweight $94 → $106
Jun-25-13Initiated ISI Group Buy $106.50
Jun-17-13Reiterated Argus Buy $95 → $115
May-03-13Reiterated Mizuho Neutral $87 → $96
Apr-12-13Reiterated Deutsche Bank Hold $89 → $94
Jul-02-15 11:39AM  Tamara Elias leaves VC firm for Becton Dickinson at Fortune
11:32AM  Becton, Dickinson (BDX) Stock Coverage Reinstated at Barclays at TheStreet
Jul-01-15 05:04PM  BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call PR Newswire
Jun-29-15 02:36PM  FlowJo and BD Partner to Streamline Flow Cytometry Data Management Business Wire
11:21AM  Becton Dickinson upgraded by UBS
Jun-27-15 11:00AM  New Study Shows Higher Rates of C. difficile Infection in Hospitals that Use Reusable Sharps Containers PR Newswire
Jun-25-15 10:12AM  Apple, Target and eight other companies with the biggest jump in earnings estimates at MarketWatch
Jun-22-15 08:30AM  3 Healthcare Stocks For A Growing Global Middle Class
Jun-12-15 02:50PM  Becton, Dickinson Alaris System Placed in WellSpan Hospitals - Analyst Blog
03:47AM  India takes first step towards regulating medical devices Reuters
Jun-11-15 06:46AM  Edited Transcript of BDX presentation 10-Jun-15 5:00pm GMT
Jun-10-15 08:30AM  WellSpan Health Implements New Infusion Pumps With Interoperability to Electronic Health Records PR Newswire
Jun-09-15 08:30AM  KLAS Report Cites Alaris® System As Leader In Interoperability With EMRs PR Newswire
Jun-06-15 10:00AM  New Clinical Data Suggest Infusion Set with BD FlowSmart Technology May Improve Insulin Flow and Reduce Silent Occlusions PR Newswire
10:00AM  New Clinical Data Suggest Infusion Set with BD FlowSmart Technology May Improve Insulin Flow and Reduce Silent Occlusions CNW Group
Jun-05-15 12:50PM  Quality Systems CEO to Quit, CareFusion Veteran to Succeed - Analyst Blog
Jun-02-15 08:00AM  BD Participates in White House Forum on Antibiotic Stewardship PR Newswire
May-29-15 08:00AM  BD to Present at Investor Healthcare Conferences PR Newswire
May-28-15 12:05PM  Becton Dickinson exploring sale of surgical instruments unit-sources
May-27-15 10:31AM  Top Healthcare, Medical Equipment Stocks of 2015 at Investopedia
08:30AM  CareFusion Provides Update on Voluntary Global Recall of AVEA® Ventilator PR Newswire
May-21-15 07:55PM  Chinese Opportunities For A Changing Child Policy at Investopedia
May-20-15 10:40AM  China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient Compliant Technologies Especially for Insulin Pump and CGM PR Newswire
May-19-15 05:25PM  BD Board Declares Dividend PR Newswire
May-15-15 01:04PM  BECTON DICKINSON & CO Financials
May-14-15 02:45PM  Becton, Dickinson Receives FDA Nod for Insulin Infusion Set - Analyst Blog
May-13-15 08:00AM  BD Receives FDA Clearance for a Novel Infusion Set with BD FlowSmart Technology to Enhance the Use of Insulin Pumps PR Newswire
08:00AM  BD Receives FDA Clearance for a Novel Infusion Set with BD FlowSmart Technology to Enhance the Use of Insulin Pumps CNW Group
May-11-15 08:12PM  10-Q for Becton, Dickinson & Co. at Company Spotlight
May-08-15 11:30AM  BECTON DICKINSON & CO Files SEC form 10-Q, Quarterly Report
May-07-15 10:21AM  Becton Dickinson (BDX) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
09:44AM  Becton, Dickinson Beats Q2 Earnings & Revenues, View Up - Analyst Blog
08:00AM  Becton, Dickinson and Co Earnings Call scheduled for 8:00 am ET today
07:56AM  Becton, Dickinson (BDX) Beat On Q2 Earnings & Revenues - Tale of the Tape
07:51AM  Early movers: BABA, PCLN, PG, COST, ANN & more at CNBC
07:49AM  Becton Dickinson Profit Drops, Pressured by Strong Dollar at The Wall Street Journal
07:07AM  Q2 2015 Becton Dickinson and Co Earnings Release - Before Market Open
06:17AM  BECTON DICKINSON & CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
06:10AM  Becton Dickinson tops Street 2Q forecasts
06:00AM  BD Announces Results For 2015 Second Fiscal Quarter PR Newswire
05:15AM  Current report no 23 / 2015 at noodls
05:15AM  Current report no 24 / 2015 at noodls
04:55AM  Budimex will complete the construction of the Hrubieszów bypass at noodls
May-05-15 02:50PM  Becton, Dickinson (BDX) Q2 Earnings: What to Expect? - Analyst Blog
04:39AM  Construction of Belchatów ring road is underway at noodls
04:39AM  Budimex has finished works in Wicko Morskie at noodls
May-04-15 06:04PM  BD to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference at noodls
04:45PM  BD to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference PR Newswire
02:40PM  Henry Schein (HSIC) Beats Q1 Earnings on Strong Revenues - Analyst Blog
May-02-15 12:01AM  An Income Manager Who Goes for Growth at Barrons.com
Apr-29-15 04:58PM  BECTON DICKINSON & CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial
08:31AM  Commentary on financial data for the first quarter of 2015 at noodls
Apr-28-15 03:56PM  FDA Consent Decree Hits Medtronic's Neuromodulation Unit - Analyst Blog
05:07AM  Current report no 22 / 2015 at noodls
05:07AM  Current report no 21 / 2015 at noodls
05:07AM  Current report no 20 / 2015 at noodls
Apr-27-15 12:01PM  Dividends could offer shelter in stormy markets at Fortune
11:40AM  Align Technology Up on Q1 Earnings Beat; Margins Rise Y/Y - Analyst Blog
Apr-23-15 09:45AM  CONMED (CNMD) Q1 Earnings, Revenues Beat; Down Y/Y - Analyst Blog
09:06AM  Becton, Dickinson and Company Announces Final Results of Exchange Offers at noodls
08:53AM  Becton, Dickinson and Company Announces Final Results of Exchange Offers PR Newswire
Apr-22-15 08:00AM  BD "Dynamic Duos" Education Campaign Aims to Help People Simplify Life with Diabetes PR Newswire
Apr-16-15 04:17PM  Today's Top 5 Stock Picks: Rock-Solid, Nice Yields at Barrons.com
Apr-14-15 08:33AM  CareFusion Demonstrates New Medication Safety Technologies At HIMSS15 at noodls
08:30AM  CareFusion Demonstrates New Medication Safety Technologies At HIMSS15 PR Newswire
05:21AM  Budimex will build an office centre in Katowice at noodls
Apr-13-15 06:04AM  The railway station in Bydgoszcz has been topped out at noodls
01:00AM  Deal or not, many U.S. states will keep sanctions grip on Iran Reuters
Apr-10-15 10:55AM  Worried About a Recession? Then Buy These 5 Stocks at Investopedia
Apr-09-15 06:22PM  Becton, Dickinson and Company Announces Results of Early Tenders and Consents in Exchange Offers at noodls
05:46PM  Becton, Dickinson and Company Announces Results of Early Tenders and Consents in Exchange Offers PR Newswire
Apr-08-15 12:23PM  CareFusion to Host Medication Safety Presentations at HIMSS15 at noodls
07:38AM  Current report no 19 / 2015 at noodls
Apr-06-15 08:52AM  BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call at noodls
08:30AM  BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call PR Newswire
Mar-27-15 10:28AM  5 Big Breakout Stocks to Trade for Big Gains: Must-See Charts at TheStreet
Mar-26-15 03:40PM  Is Becton, Dickinson Mulling the Sale of its Respiratory Unit? - Analyst Blog
10:06AM  Farallon Capital Adds a New Position in CareFusion Corporation
08:39AM  Becton, Dickinson and Company to Commence Exchange Offers at noodls
08:30AM  Becton, Dickinson and Company to Commence Exchange Offers PR Newswire
06:45AM  Current report no 18 / 2015 at noodls
06:39AM  Current report no 17 / 2015 at noodls
06:34AM  Current report no 16 / 2015 at noodls
06:26AM  Current report no 15 / 2015 at noodls
06:21AM  Current report no 14 / 2015 at noodls
Mar-24-15 07:03PM  Becton Dickinson Said to Plan Asset Sales After CareFusion Deal at Bloomberg
Mar-18-15 12:40PM  Becton, Dickinson & CareFusion Unite; Moody's Not Happy - Analyst Blog
03:32AM  A consortium of Budimex and Ferrovial Agroman chosen to build another section of the S7 at noodls
Mar-17-15 07:49PM  Becton, Dickinson and Company -- Moody's downgrades Becton Dickinson's ratings to Baa2 from A3; outlook stable at Moody's
10:31AM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:30AM  BECTON DICKINSON COMPLETES ACQUISITION OF CAREFUSION at noodls
09:29AM  European Commission Clears BD Acquisition Of CareFusion at noodls
09:29AM  Becton Dickinson Completes Acquisition Of CareFusion at noodls
09:00AM  Becton Dickinson Completes Acquisition Of CareFusion PR Newswire
08:28AM  3 Favorite Dividend Stocks at Hedge Fund Renaissance Technologies at TheStreet
04:11AM  Current report no 13 / 2015 at noodls
Mar-16-15 01:10PM  European Regulator Oks Becton, Dickinson-CareFusion Deal - Analyst Blog
12:49PM  EU mergers and takeovers (March 16) Reuters
Mar-13-15 05:50PM  Celgene, Kinder Morgan and Actavis Set to Join the S&P 100; Several Constituent Changes Announced for S&P 500, S&P MidCap 400 and S&P SmallCap 600 PR Newswire
05:37PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment produces medical devices, such as needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for use in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Life Sciences segment provides products for the collection and transportation of diagnostics specimens; and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections, and cancers. This segment's products include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood and tuberculosis culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. It also offers research and clinical tools, such as fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. In addition, the company develops technologies that address biological analysis protocols, including library preparation of next generation sequencing and genotyping applications. Becton, Dickinson and Company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sichak StephenExecutive Vice PresidentJun 01Option Exercise70.1216,9701,190,00820,395Jun 02 05:05 PM
Sichak StephenExecutive Vice PresidentJun 01Sale140.9412,1881,717,81310,541Jun 02 05:05 PM
Polen Thomas E JrExecutive Vice PresidentMay 22Option Exercise76.642,670204,6297,609May 22 05:01 PM
Polen Thomas E JrExecutive Vice PresidentMay 22Sale142.563,882553,4094,939May 22 05:01 PM
KOZY WILLIAM AExecutive Vice PresidentMay 20Option Exercise62.5018,4551,153,43892,163May 21 10:44 AM
KOZY WILLIAM AExecutive Vice PresidentMay 20Sale142.0010,3261,466,29273,708May 21 10:44 AM
KOZY WILLIAM AExecutive Vice PresidentMay 19Option Exercise77.0416,3681,260,96984,609May 20 04:18 PM
KOZY WILLIAM AExecutive Vice PresidentMay 19Sale142.017,4881,063,37173,708May 20 04:18 PM
Lim James CExecutive Vice PresidentMay 18Option Exercise76.747,848602,28717,436May 19 02:48 PM
KOZY WILLIAM AExecutive Vice PresidentMay 18Option Exercise84.337,256611,89880,964May 20 04:18 PM
KOZY WILLIAM AExecutive Vice PresidentMay 18Sale142.002,947418,47473,708May 20 04:18 PM
Mecklenburg Gary ADirectorMay 18Sale141.602,160305,85620,965May 19 09:39 AM
SCOTT BERTRAM LDirectorMay 18Sale141.742,160306,15822,416May 19 09:38 AM
Lim James CExecutive Vice PresidentMay 18Sale141.803,604511,04711,278May 19 02:48 PM
Conroy AlexandreExecutive Vice PresidentMay 15Option Exercise84.333,200269,85620,375May 15 04:45 PM
Conroy AlexandreExecutive Vice PresidentMay 15Sale141.371,291182,50917,175May 15 04:45 PM
SHERMAN JEFFREY SExec VP and General CounselMay 13Option Exercise84.3312,3801,044,00538,466May 14 06:11 PM
SHERMAN JEFFREY SExec VP and General CounselMay 13Sale138.4010,9831,520,04726,086May 14 06:11 PM
Hurwitz Jerome VExecutive Vice PresidentMay 11Option Exercise84.332,958249,4487,824May 12 05:05 PM
Hurwitz Jerome VExecutive Vice PresidentMay 11Sale141.431,197169,2924,866May 12 05:05 PM
COHEN GARY MExecutive Vice PresidentMay 08Option Exercise62.5023,9221,495,12596,237May 11 04:10 PM
Shabshab NabilExecutive Vice PresidentMay 08Option Exercise73.8022,5021,660,70817,438May 11 04:15 PM
Shabshab NabilExecutive Vice PresidentMay 08Sale141.8813,9961,985,7794,262May 11 04:15 PM
COHEN GARY MExecutive Vice PresidentMay 08Sale142.9013,4901,927,72172,315May 11 04:10 PM
BECTON HENRY P JRDirectorMar 19Option Exercise138.081,010139,461114,763Mar 20 02:55 PM
Mecklenburg Gary ADirectorJan 14Option Exercise57.212,160123,57421,696Jan 14 03:09 PM
BECTON HENRY P JRDirectorJan 12Option Exercise57.212,160123,574113,753Jan 14 10:24 AM
HUM Humana Inc. daily Stock Chart
HUM [NYSE]
Humana Inc.
IndexS&P 500 P/E24.19 EPS (ttm)7.81 Insider Own0.20% Shs Outstand149.78M Perf Week-3.35%
Market Cap28.30B Forward P/E19.24 EPS next Y9.82 Insider Trans-31.71% Shs Float149.11M Perf Month-11.16%
Income1.21B PEG2.07 EPS next Q2.37 Inst Own95.90% Short Float2.50% Perf Quarter6.16%
Sales50.62B P/S0.56 EPS this Y-4.80% Inst Trans-0.01% Short Ratio1.59 Perf Half Y32.55%
Book/sh66.74 P/B2.83 EPS next Y13.61% ROA5.00% Target Price190.39 Perf Year46.16%
Cash/sh12.99 P/C14.54 EPS next 5Y11.71% ROE12.10% 52W Range114.69 - 219.47 Perf YTD31.96%
Dividend1.16 P/FCF83.98 EPS past 5Y3.70% ROI9.70% 52W High-13.90% Beta0.95
Dividend %0.61% Quick Ratio- Sales past 5Y9.50% Gross Margin- 52W Low64.76% ATR7.54
Employees57000 Current Ratio- Sales Q/Q18.10% Oper. Margin4.80% RSI (14)45.80 Volatility3.19% 3.61%
OptionableYes Debt/Eq0.41 EPS Q/Q20.00% Profit Margin2.40% Rel Volume5.95 Prev Close187.50
ShortableYes LT Debt/Eq0.38 EarningsJul 29 BMO Payout14.20% Avg Volume2.34M Price188.96
Recom2.40 SMA20-5.67% SMA500.38% SMA20019.10% Volume13,941,123 Change0.78%
Jul-06-15Downgrade Wedbush Outperform → Neutral
Jul-02-15Reiterated Argus Buy $180 → $220
Jun-24-15Initiated RBC Capital Mkts Sector Perform $221
Jun-03-15Upgrade Sterne Agee CRT Underperform → Neutral
Jun-01-15Reiterated Deutsche Bank Hold $155 → $220
Jun-01-15Reiterated Cantor Fitzgerald Buy $160 → $230
May-13-15Downgrade Sterne Agee Neutral → Underperform
Apr-30-15Reiterated Oppenheimer Outperform $193 → $188
Apr-30-15Reiterated FBR Capital Outperform $145 → $150
Mar-24-15Reiterated Oppenheimer Outperform $167 → $193
Feb-23-15Reiterated Argus Buy $155 → $180
Feb-05-15Reiterated FBR Capital Mkt Perform $132 → $145
Jan-06-15Reiterated Argus Buy $135 → $155
Jul-31-14Reiterated Barclays Equal Weight $120 → $128
Jun-06-14Upgrade Stifel Hold → Buy $155
May-22-14Reiterated Argus Buy $125 → $135
May-08-14Reiterated Oppenheimer Outperform $105 → $125
May-08-14Reiterated Barclays Equal Weight $105 → $120
May-07-14Reiterated FBR Capital Mkt Perform $99 → $110
Mar-12-14Reiterated UBS Neutral $95 → $112
Jul-07-15 12:06AM  Deal-Related Jitters Hit Humana, Aetna at The Wall Street Journal
Jul-06-15 07:18PM  Aetna-Humana Merger: Why Investors Are Uncertain and Wary - Stocks in the News
07:13PM  Deal-Related Jitters Hit Humana, Aetna at The Wall Street Journal
06:32PM  Aetna CEO addresses antitrust concerns over Humana deal Reuters
06:26PM  Aetna-Humana Deal May Never Be Consummated at Barrons.com
06:21PM  Aetna Plunges After $37 Billion Humana Acquisition at TheStreet
06:20PM  Humana cuts outlook, raising new concerns about Aetna deal Reuters
05:43PM  HUMANA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Humana Inc. PR Newswire
05:14PM  Aetna Plunges to Trail S&P 500 Following $37B Humana Acquisition at TheStreet
04:53PM  Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Humana Inc. Business Wire
04:30PM  Jack Levy's Swan Song: Selling Humana at The Wall Street Journal
04:20PM  Monday brought more volatility for equity markets...
04:19PM  Late Rally Comes Up Short; Heritage Insurance Hits New High at Investor's Business Daily
04:09PM  US stocks end lower after Greek 'no' vote; Europe sinks
03:52PM  Dow dips on Greece concerns; energy sector fizzles at CNBC
03:28PM  Aetna strikes first, acquiring Humana in largest insurance deal in history
03:08PM  Aetna to Buy Humana in a $37B Cash-and-Stock Transaction at TheStreet
03:00PM  How much does The Humana Foundation give to Louisville? at bizjournals.com
02:44PM  Social Media Beat: China, Greece, Crude Oil And The Aetna-Humana Deal
02:37PM  Robbins Arroyo LLP: Acquisition of Humana Inc. (HUM) by Aetna Inc. (AET) May Not Be in Shareholders' Best Interests PR Newswire
02:32PM  Getting money to Greece
02:31PM  How The Street Is Reacting To The Aetna-Humana Deal
02:24PM  How to Trade 4 of the Market's Most Active Stocks at TheStreet
02:12PM  HUMANA SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Aetna Business Wire
02:03PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Humana, Inc. of Commencement of an Investigation Regarding the Fairness of the Sale of the Company to Aetna, Inc. -- HUM PR Newswire
01:55PM  How the Aetna-Humana Deal Could Open Floodgates for Insurance Mergers at TheStreet
01:40PM  Trending Now: Humana
01:31PM  Health care insurer stocks mixed after Aetna, Humana deal
01:17PM  Mid-Day Market Update: Weight Watchers Surges On Takeover Rumors; Horsehead Holding Shares Drop
01:10PM  Megamergers could reshape health insurance marketplace (Video) at bizjournals.com
12:39PM  Investors Wary of Aetna-Humana Deal at The Wall Street Journal
12:27PM  4 Stocks, 4 trades: GPRO, TRIP, WTW & AET
12:09PM  Aetna, Humana CEOs Say Industry Consolidation Good for Consumer at Fox Business
11:25AM  Aetna & Humana rush to deal; Guess lifted; Weight Watchers gain
11:23AM  Worries Surface About Aetna's Credit After Humana Purchase at Barrons.com
11:07AM  Low rates weigh on insurers even as it feeds their merger mania at Financial Times
10:45AM  Health Insurance Mergers Falling Into Place at 24/7 Wall St.
10:43AM  Stocks Pare Losses, Oil Slumps; Intuitive Surgical, Aetna Slide at Investor's Business Daily
10:36AM  Mid-Morning Market Update: Markets Open Lower; Aetna To Acquire Humana For $230/Share
10:35AM  [$$] With Merger Deal, Aetna, Humana Get Ahead of the Pack at The Wall Street Journal
10:30AM  The $37B merger that can affect your health at CNBC
10:30AM  HUMANA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Humana Inc. (HUM) Over the Proposed Sale of the Company to Aetna Inc. PR Newswire
10:29AM  Aetna: Not Much to Get Excited About in Humana Acquisition at Barrons.com
10:23AM  HUMANA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
10:15AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Humana, Inc. of Commencement of an Investigation Regarding the Fairness of the Sale of the Company to Aetna, Inc. -- HUM Business Wire
09:54AM  Aetna-Humana Deal Could Create PBM, Ending CVS Relationship at Forbes
09:52AM  Humana (HUM) Stock Up on Aetna Merger Agreement at TheStreet
09:44AM  Aetna CEO says built expectations for asset sales into deal
09:38AM  US stocks open lower after Greek vote
09:34AM  Humana Cuts Outlook After Aetna Announces Buyout at Investor's Business Daily
09:33AM  Faber Report: Aetna-Humana merger
09:32AM  Dow falls 100 points in open after Greece 'no' vote at CNBC
09:23AM  Greece needs Draghi: Art Cashin
09:16AM  Stock Futures Fall On Greek Vote; $34 Bil Deal Lifts Aetna, Humana at Investor's Business Daily
09:10AM  Weight Watchers buyer? Nike's World Cup move; Humana warning
09:02AM  Aetna's Humana Deal Pressures Cigna to Agree on Anthem Offer
09:00AM  Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Humana, Inc. Concerning its Proposed Sale to Aetna Inc. PR Newswire
08:54AM  Aetna-Humana Deal Are 'Right Partners,' Companies Say
08:51AM  Health care's urge to merge
08:32AM  Weight Watchers soars as activist circles; Humana higher on Aetna bid at MarketWatch
08:26AM  Deals of the Day: Latest on the Health-Insurer Front, Samsung Setback at The Wall Street Journal
08:08AM  Humana provides downbeat profit outlook ahead of discussion of Aetna buyout at MarketWatch
08:06AM  Markets plunge amid Greek drama; Private tech stock probe; Nike's big World Cup score
08:05AM  Humana, Aetna hope deal will give them edge in antitrust review at bizjournals.com
07:44AM  Early movers: HUM, SRG, AAPL, POT, BABA & more at CNBC
07:40AM  Morning Movers: Weight Watchers Jumps on Takeover Talk; Aetna Tumbles on Humana Acquisition at Barrons.com
07:39AM  HUMANA INC Files SEC form 8-K, Results of Operations and Financial Condition
06:30AM  Aetna-Humana deal puts WellCare in the spotlight at bizjournals.com
12:19AM  Aetna and Humana: Justifying the Prize at The Wall Street Journal
12:18AM  With Merger Deal, Aetna, Humana Get Ahead of the Pack at The Wall Street Journal
12:18AM  How the Affordable Care Act Is Reducing Competition at The Wall Street Journal
12:01AM  Aetnas Humana Deal Pressures Cigna to Agree on Anthem Takeover at Bloomberg
Jul-05-15 08:03PM  Aetna, Humana Hurry to the Altar at The Wall Street Journal
07:52PM  Futures Sink Sharply as Greece's 'No' Camp Looks Set to Win at TheStreet
06:44PM  How the Affordable Care Act Is Reducing Competition at The Wall Street Journal
02:10PM  Aetna and Humana: Justifying the Prize at The Wall Street Journal
Jul-04-15 11:28AM  Insurers choose partners, and dance floor shrinks at CNBC
Jul-03-15 10:20PM  Rivals Lurked Behind Aetna's Deal With Humana at The Wall Street Journal
07:30PM  Aetna to buy Humana as health insurer landscape shifts
06:27PM  Aetna to buy Humana for $37bn in cash and shares at Financial Times
04:56PM  Humana & Aetna: Finally at Barrons.com
04:13PM  Aetna's Humana deal to bring scrutiny on other insurer tie-ups -experts Reuters
03:56PM  Aetna, Humana CEOs say deal bolsters Medicare, Medicaid businesses at USA TODAY
02:56PM  Aetna-Humana Merger Marks Sway of Health-Care Law at The Wall Street Journal
02:34PM  Hedge Funds Were Right About Humana Inc (HUM) at Insider Monkey
01:20PM  Seven interesting things Humana is telling employees and stakeholders at bizjournals.com
12:36PM  Aetna to Buy Humana for $37 Billion in Cash and Stock at TheStreet
12:32PM  Aetna to buy Humana for $37 billion in largest insurance deal Reuters
12:28PM  Aetna to buy Humana for $37 bln in largest insurance deal Reuters
11:16AM  Aetna buys Humana for $37B amid record number of health care deals at USA TODAY
10:57AM  Aetna's $37B Humana Deal Expands Role In Medicare's Value-Based Care Push at Forbes
10:16AM  Aetna Buys Humana For $37 Billion, But Deal Doesn't Add Up at Forbes
10:09AM  Humana Inc. -- Moody's reviews Humana's ratings (sr. debt at Baa3) for upgrade following announcement of acquisition by Aetna at Moody's
09:50AM  Humana (HUM) to be Acquired by Aetna for $37B by 2H16 - Analyst Blog
09:46AM  Humana CEO told employees of sale via email at 2:38 a.m. at bizjournals.com
09:05AM  Insurer Aetna to buy Humana in $35B deal
07:58AM  Let's make a deal: mega-mergers drive M&A frenzy
07:26AM  Insurer Aetna to buy Humana in $37B deal
07:10AM  SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Humana Inc. and Encourages Investors to Contact the Firm for Additional Information Business Wire
06:42AM  Aetna is buying Humana for $37 billion
Humana Inc., together with its subsidiaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals. This segment has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program and state-based Medicaid businesses. The Group segment offers Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary benefit products, as well as administrative services only products, and health and wellness solutions directly to employer groups. The Healthcare Services segment provides pharmacy, provider services, home based services, integrated behavioral health services, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also offers military services, such as TRICARE South Region contract; Puerto Rico Medicaid; and closed-block long-term care insurance policies. As of March 31, 2015, the company had approximately 14.2 million members in medical benefit plans, and approximately 7.4 million members in specialty products. The company was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MURRAY JAMES EEVP & COOMar 11Sale161.14678109,2516,522Mar 12 03:34 PM
MURRAY JAMES EEVP & COOMar 11Sale160.9034,5425,557,72260,108Mar 12 03:34 PM
LeClaire Brian P.SVP & Chief Information Off.Mar 02Sale161.795,500889,82911,965Mar 03 05:20 PM
BROUSSARD BRUCE DPresident & CEOFeb 25Option Exercise90.1942,4873,831,820102,431Feb 26 06:16 PM
JONES DAVID A JR/KYDirectorFeb 25Sale165.396,1001,008,903127,050Feb 27 03:30 PM
BROUSSARD BRUCE DPresident & CEOFeb 25Sale165.2941,1056,794,35660,720Feb 26 06:16 PM
MARGULIS HEIDI SSenior V.P. - Public AffairsFeb 24Option Exercise72.842,744199,87313,383Feb 25 06:33 PM
Christopher M TodoroffSr. VP and General CounselFeb 24Option Exercise84.2633,7342,842,47754,196Feb 26 05:17 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 24Option Exercise86.118,231708,74425,696Feb 26 06:07 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 24Sale164.528,2311,354,17217,465Feb 26 06:07 PM
Christopher M TodoroffSr. VP and General CounselFeb 24Sale164.3139,2976,456,69414,899Feb 26 05:17 PM
MARGULIS HEIDI SSenior V.P. - Public AffairsFeb 24Sale164.443,665602,6730Feb 25 06:33 PM
Christopher M TodoroffSr. VP and General CounselFeb 23Option Exercise0.174,73879022,157Feb 25 06:45 PM
MARGULIS HEIDI SSenior V.P. - Public AffairsFeb 23Option Exercise0.172,82047011,550Feb 25 06:33 PM
MURRAY JAMES EEVP & COOFeb 23Option Exercise0.179,4761,58098,271Feb 25 06:10 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 23Option Exercise0.001,97401,974Feb 25 06:00 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 23Option Exercise0.176,7681,12819,964Feb 25 05:40 PM
LeClaire Brian P.SVP & Chief Information Off.Aug 22Sale123.043,250399,88713,196Aug 25 01:17 PM
AR Antero Resources Corporation daily Stock Chart
AR [NYSE]
Antero Resources Corporation
Index- P/E7.32 EPS (ttm)4.41 Insider Own72.70% Shs Outstand277.00M Perf Week-8.03%
Market Cap8.95B Forward P/E42.33 EPS next Y0.76 Insider Trans-0.26% Shs Float76.45M Perf Month-15.84%
Income1.16B PEG0.27 EPS next Q0.09 Inst Own30.40% Short Float8.68% Perf Quarter-13.08%
Sales3.74B P/S2.39 EPS this Y-48.30% Inst Trans0.29% Short Ratio3.97 Perf Half Y-23.73%
Book/sh20.14 P/B1.60 EPS next Y22.87% ROA11.20% Target Price47.54 Perf Year-50.84%
Cash/sh0.67 P/C48.23 EPS next 5Y27.61% ROE27.40% 52W Range33.17 - 65.73 Perf YTD-20.40%
Dividend- P/FCF- EPS past 5Y51.90% ROI9.50% 52W High-50.86% Beta-
Dividend %- Quick Ratio1.10 Sales past 5Y66.70% Gross Margin96.70% 52W Low-2.62% ATR1.01
Employees444 Current Ratio1.10 Sales Q/Q631.10% Oper. Margin56.00% RSI (14)15.84 Volatility2.86% 2.77%
OptionableYes Debt/Eq0.78 EPS Q/Q513.90% Profit Margin31.10% Rel Volume2.18 Prev Close33.25
ShortableYes LT Debt/Eq0.78 EarningsAug 05 AMC Payout0.00% Avg Volume1.67M Price32.30
Recom2.20